Zerify (ZRFY) S-1/A 3 Aug 23 IPO registration (amended) Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2023
Cover [Abstract]
Entity Registrant Name	Zerify, Inc.
Entity Central Index Key	0001285543
Document Type	S-1/A
Amendment Flag	true
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Filer Category	Non-accelerated Filer
Amendment Description	Amendment Description
Entity Incorporation State Country Code	WY
Entity Tax Identification Number	22-3827597
Entity Address Address Line 1	1090 King Georges Post Road
Entity Address Address Line 2	Suite 603
Entity Address City Or Town	Edison
Entity Address State Or Province	NJ
Entity Address Postal Zip Code	08837
City Area Code	732
Local Phone Number	661-9641

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash (includes VIE balances of $1,000 and $1,000, respectively)	$ 229,000	$ 192,000	$ 2,084,000
Accounts receivable, net	20,000	20,000	24,000
Prepaid expenses		0	13,000
Total current assets	249,000	212,000	2,121,000
Property and equipment, net	34,000	36,000	0
Operating lease right-of-use asset	41,000	54,000	107,000
Other assets	10,000	11,000	12,000
Total Assets	334,000	313,000	2,240,000
Current Liabilities:
Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively)	1,336,000	1,160,000	996,000
Convertible notes payable, net of discount of $96,000 and $0, respectively (including $895,000 and $895,000 in default)	1,318,000	1,282,000	1,398,000
Notes payable, net of discount of $323,000 and $0, respectively (including $1,930,000 and $1,972,000 in default, respectively) (includes VIE balances of $285,000 and $310,000, respectively)	2,966,000	2,826,000	1,972,000
Notes payable - related parties	693,000	693,000	693,000
Accrued interest (including $1,557,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $134,000 and $120,000, respectively)	5,958,000	5,865,000	5,477,000
Contingent payment obligation	1,500,000	1,500,000	1,500,000
VIE Financing obligation	1,263,000	1,263,000	1,263,000
Operating lease liability, current portion	44,000	56,000	39,000
Derivative liability	265,000	112,000	0
Total current liabilities	15,611,000	15,025,000	13,606,000
Notes payable, long-term portion	142,000	142,000	150,000
Operating lease liability, long-term portion	0	1,000	73,000
Convertible notes payable - related parties	268,000	268,000	268,000
Total Liabilities	15,753,000	15,168,000	13,829,000
Stockholders' Deficit
Preferred stock, Value	0	0	0
Common stock par value $0.0001: 10,000,000,000 shares authorized; 1,109,417,572 and 955,380,225 shares issued and outstanding, respectively	128,000	110,000	96,000
Additional paid-in capital	68,211,000	67,124,000	59,788,000
Accumulated deficit	(83,837,000)	(82,190,000)	(71,595,000)
Total Zerify, Inc. stockholders' deficit	(14,507,000)	(13,965,000)	(10,720,000)
Noncontrolling interest in consolidated subsidiary	(912,000)	(890,000)	(869,000)
Total Stockholders' Deficit	(15,419,000)	(14,855,000)	(11,589,000)
Total Liabilities and Stockholders' Deficit	334,000	313,000	2,240,000
Series B Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, Value	4,000	4,000	4,000
Series A Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, Value	$ 987,000	$ 987,000	$ 987,000

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current Assets
Cash VIE	$ 0	$ 1,000	$ 1,000
Current Liabilities
VIE Balance of Accounts Payables and Accrued Liabilities		4,000	2,000
Allowance on convertible notes payable		96,000	0
Convertible notes payable, default		895,000	895,000
Notes payable VIE		285,000	310,000
Allowance on notes payable		323,000	0
Notes payable, default	136,000	323,000	1,972,000
Accrued Interest VIE		134,000	120,000
Accounts payables (includes VIE balances)	4,000	2,000
Accrued interest due to related parties		1,557,000	$ 1,497,000
Convertible notes payable, default	204,000	96,000
Convertible notes payable, default (Including )	895,000	895,000
Notes payable, default including	1,930,000	1,930,000
Notes payable, Including VIE	285,000	285,000
Accrued interest Including	1,648,000	1,557,000
Accrued interest Includin VIE	$ 155,000	$ 134,000
Stockholders' Deficit
Preferred Stock, share par value	$ 0.10	$ 0.10	$ 0.10
Preferred stock, shares authorized	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000,000	10,000,000,000	4,000,000,000
Common stock, shares issued	1,109,417,572	1,109,417,572	955,380,225
Common stock, shares outstanding	1,109,417,572	1,109,417,572	955,380,225
Series B Preferred Stock [Member]
Stockholders' Deficit
Preferred Stock, share par value	$ 0.10	$ 0.10	$ 0.10
Preferred stock, shares authorized	100,000,000	100,000,000	100,000,000
Preferred stock, shares issued	36,667	36,667	36,667
Preferred stock, shares outstanding	36,667	36,667	36,667
Series A Preferred Stock [Member]
Stockholders' Deficit
Preferred Stock, share par value	$ 0	$ 0
Preferred stock, shares authorized	100	100	100
Preferred stock, shares issued	3	3	3
Preferred stock, shares outstanding	3	3	3

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 22,000	$ 32,000	$ 103,000	$ 193,000
Operating expenses:
Cost of revenue	17,000	10,000	34,000	27,000
Selling, general and administrative expenses	1,166,000	2,636,000	7,711,000	9,448,000
Research and development	157,000	154,000	580,000	566,000
Total operating expenses	1,340,000	2,800,000	8,325,000	10,041,000
Total operating expenses	1,340,000	2,800,000	8,325,000	10,041,000
Loss from operations	(1,318,000)	(2,768,000)	(8,222,000)	(9,848,000)
Loss from operations	(1,318,000)	(2,768,000)	(8,222,000)	(9,848,000)
Interest and financing expenses (including $30,000 and $30,000 to related parties)	(140,000)	(99,000)
Other income (expense):
Interest and financing expenses (including $121,000 and $121,000 to related parties)			(516,000)	(7,016,000)
Debt discount amortization	(233,000)	0	(141,000)	(52,000)
Change in fair value of derivative liabilities	22,000	0	52,000	(219,000)
Other income (expense), net	(351,000)	(99,000)	(607,000)	(7,397,000)
Loss on extinguishment of debt, net			0	(109,000)
Other expense			(2,000)	(1,000)
Net loss	(1,669,000)	(2,867,000)	(8,829,000)	(17,245,000)
Net loss attributable to noncontrolling interest	22,000	7,000	21,000	46,000
Net loss attributable to Zerify, Inc.	$ (1,647,000)	$ (2,860,000)	(8,808,000)	(17,199,000)
Deemed dividend to warrant holders			(1,787,000)	0
Net loss to common stockholders			$ (10,595,000)	$ (17,199,000)
Net loss per common share
-Basic and diluted	$ 0	$ 0	$ (0.01)	$ (0.02)
Weighted average common shares outstanding
-Basic and diluted	1,176,808,681	955,465,906	1,001,263,673	868,770,818

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Total	Series A Preferred Stock	Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest
Balance, shares at Dec. 31, 2020		3	36,667	718,263,338
Balance, amount at Dec. 31, 2020	$ (14,342,000)	$ 987,000	$ 4,000	$ 72,000	$ 39,814,000	$ (54,396,000)	$ (823,000)
Common stock issued for cash, shares				119,666,450
Common stock issued for cash, amount	5,368,000	0	0	$ 12,000	5,356,000	0	0
Fair value of common stock issued for services, amount	181,000	0	0	$ 1,000	180,000	0	0
Fair value of common stock issued for services, shares				3,365,138
Fair value of vested options	6,757,000	0	0	$ 0	6,757,000	0	0
Net loss	17,245,000
Fair value of common stock issued as a financing cost, shares				45,150,500
Fair value of common stock issued as a financing cost, amount	6,569,000	0	0	$ 5,000	6,564,000	0	0
Common stock issued upon cashless exercise of warrants, shares				12,349,726
Common stock issued upon cashless exercise of warrants, amount	0	0	0	$ 1,000	(1,000)	0	0
Common stock issued upon cashless exercise of options, shares				39,955,655
Common stock issued upon cashless exercise of options, amount	0	0	0	$ 3,000	(3,000)	0	0
Common stock issued upon conversion of notes and accrued interest, shares				16,168,589
Common stock issued upon conversion of notes and accrued interest, amount	1,035,000	0	0	$ 2,000	1,033,000	0	0
Common stock issued upon conversion of debt settlement, shares				460,829
Common stock issued upon conversion of debt settlement, amount	88,000	0	0	$ 0	88,000	0	0
Net loss	(17,245,000)	0	0	0	0	(17,199,000)	(46,000)
Balance, amount at Dec. 31, 2021	(11,589,000)	$ 987,000	$ 4,000	$ 96,000	59,788,000	(71,595,000)	(869,000)
Balance, shares at Dec. 31, 2021		3	36,667	955,380,225
Fair value of common stock issued for services, amount	6,000				6,000
Fair value of common stock issued for services, shares				134,853
Fair value of vested options	1,636,000				1,636,000
Net loss	(2,867,000)					(2,860,000)	(7,000)
Net loss	(2,867,000)
Balance, amount at Mar. 31, 2022	(12,814,000)	$ 987,000	$ 4,000	$ 96,000	61,430,000	(74,455,000)	(876,000)
Balance, shares at Mar. 31, 2022		3	36,667	955,515,078
Balance, shares at Dec. 31, 2021		3	36,667	955,380,225
Balance, amount at Dec. 31, 2021	(11,589,000)	$ 987,000	$ 4,000	$ 96,000	59,788,000	(71,595,000)	(869,000)
Common stock issued for cash, shares				40,100,000
Common stock issued for cash, amount	180,000	0	0	$ 3,000	177,000	0	0
Fair value of common stock issued for services, amount	423,000	0	0	$ 3,000	420,000
Fair value of common stock issued for services, shares				30,105,936
Fair value of vested options	2,990,000				2,990,000
Net loss	8,829,000
Net loss	(8,829,000)	0				(8,808,000)	(21,000)
Common stock issued upon exercise of warrants for cash, shares				100,000,000
Common stock issued upon exercise of warrants for cash, amount	1,440,000	0	0	$ 10,000	1,430,000	0	0
Fair value of warrants granted for services	435,000	0	0	0	435,000	0	0
Fair value of warrants issued with notes payable accounted for as debt discount	260,000	0	0	$ 0	260,000	0	0
Deemed dividend to warrant holders	0				1,787,000	(1,787,000)
Repurchase of common stock and warrants, shares				(16,168,589)
Repurchase of common stock and warrants, amount	(165,000)			$ (2,000)	(163,000)
Balance, amount at Dec. 31, 2022	(14,855,000)	$ 987,000	$ 4,000	$ 110,000	67,124,000	(82,190,000)	(890,000)
Balance, shares at Dec. 31, 2022		3	36,667	1,109,417,572
Net loss	(1,669,000)	$ 0	$ 0	$ 0	0	(1,647,000)	(22,000)
Vested stock options	292,000				292,000
Sale of common shares and warrants, shares				176,599,998
Sale of common shares and warrants, amount	795,000	0	0	$ 18,000	777,000	0	0
Proceeds on the sale of warrants	18,000	0	0	0	18,000	0	0
Net loss	(1,669,000)
Balance, amount at Mar. 31, 2023	$ (15,419,000)	$ 987,000	$ 4,000	$ 128,000	$ 68,211,000	$ (83,837,000)	$ (912,000)
Balance, shares at Mar. 31, 2023		3	36,667	1,286,017,570

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ 1,669,000	$ 2,867,000	$ (8,829,000)	$ (17,245,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			3,000	4,000
Amortization of discount	233,000	0	141,000	52,000
Financing costs			64,000	0
Right-of-use asset	13,000	13,000	53,000	51,000
Fair value of common stock issued for services			423,000	181,000
Fair value of vested options and warrants	292,000	1,636,000	3,425,000	6,757,000
Fair value of common stock issued for financing services	0	6,000	0	6,569,000
Change in fair value of derivative liabilities			(52,000)	219,000
Depreciation	2,000	0
Loss on extinguishment of debt			0	112,000
Changes in operating assets and liabilities:
Accounts receivable	0	10,000	4,000	(4,000)
Prepaid expenses and other assets			14,000	8,000
Accounts payable and accrued expenses	176,000	46,000	163,000	(14,000)
Financing costs	21,000	0
Accrued interest	93,000	99,000	388,000	298,000
Operating lease liability	(13,000)	(14,000)	(55,000)	(51,000)
Net cash used in operating activities	(873,000)	(1,060,000)	(4,258,000)	(3,063,000)
Cash flows from investing activities:
Purchases of property and equipment	0	(24,000)	(39,000)	0
Net cash used in investing activities	0	(24,000)	(39,000)	0
Change in fair value of derivative liabilities	(22,000)	0	(52,000)	219,000
Cash flows from financing activities:
Proceeds from exercise of warrants			1,440,000	0
Changes in operating assets and liabilities:
Proceeds from sale of common stock	795,000	0	180,000	5,368,000
Proceeds from sale warrants	18,000	0
Prepaid expenses and other assets	1,000	11,000
Proceeds from sale of convertible notes			100,000	0
Proceeds from notes payable	154,000	0	1,075,000	177,000
Repayment of convertible note payable	(10,000)	(20,000)	(120,000)	(40,000)
Repayment of notes payable	(47,000)	(6,000)	(105,000)	(231,000)
Repurchase of common stock and warrants			(165,000)
Repayment of convertible notes payable-related parties			0	(30,000)
Repayment of notes payable-related parties			0	(259,000)
Net cash provided by financing activities	910,000	(26,000)	2,405,000	4,985,000
Net increase (decrease) in cash	37,000	(1,110,000)	(1,892,000)	1,922,000
Cash at beginning of the year	192,000	2,084,000	2,084,000	162,000
Cash at end of the year	229,000	974,000	192,000	2,084,000
Supplemental disclosure of cash flow information:
Interest paid	0	0	8,000	120,000
Income tax paid	0	0	0	0
Supplemental disclosure of non-cash investing and financing transactions
Fair value of derivative upon issuance of convertible debt recorded as debt discount	$ 176,000	$ 0	164,000	0
Fair value of warrant recorded as debt discount			260,000	0
Common stock issued for conversion of notes and accrued interest			0	1,035,000
Common shares issued upon conversion of debt settlement			0	88,000
Warrants issued with convertible notes			$ 0	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization and Summary of Significant Accounting Policies
Organization and Summary of Significant Accounting Policies	Note 1 - Organization and Summary of Significant Accounting Policies Zerify, Inc. (formerly known as StrikeForce Technologies, Inc.) (the “Company”), a software development and services company, offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey. On April 26, 2022, the Company applied for the Zerify trademark, ZERIFY™, which is intended to cover the categories of: · downloadable or recorded computer software for encryption; · downloadable or recorded computer software for cyber security assessment and protection; · anti-spyware software; downloadable or recorded computer application software for mobile devices, namely, software for protecting people from identity theft; · downloadable or recorded computer software for guarding users of computers and remote access devices from identity theft, featuring various software tools, namely, anti-keyboard logger and keyboard stroke encryption. On June 14, 2022, the Company’s Board of Directors and by consent majority shareholder vote approved changing the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc. The name change was made to better reflect the Company’s business plans centered around its cyber security software products. On August 1, 2022, FINRA approved the Company’s Common Stock being quoted on the OTCQB Market under the symbol “ZRFY”, however, on January 19, 2023 we became quoted on the OTC Markets Pink as a result of our common stock being quoted below $0.01. Basis of presentation and principles of consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been included. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023. These financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2022 and notes thereto contained in the Annual Report on Form 10-K of the Company as filed with the SEC on April 14, 2023. The condensed consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. The Company and BST have a management agreement pursuant to which BST shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three-year period. The management fee is eliminated in consolidation. At March 31, 2023 and December 31, 2022, the amount of VIE cash on the accompanying condensed consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors. Going Concern The Company has yet to establish any history of profitable operations. During the three months ended March 31, 2023, the Company incurred a net loss of $1,669,000 and used cash in operating activities of $873,000 and at March 31, 2023, the Company had a stockholders’ deficit of $15,419,000. In addition, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report published on our December 31, 2022 year-end financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern. Management estimates that the current funds on hand will be sufficient to continue operations through the next few months. Our ability to continue as a going concern is dependent upon our ability to continue to implement our business plan. Currently, management is attempting to increase revenues by selling through a channel of new distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of its strategy to increase revenues, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution to its stockholders, in the case of equity financing. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary concerns, on its business and operations. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing equity instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. Revenue Recognition The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of the Company’s products. The following tables present our revenue disaggregated by major product and service lines: Three Months Ended March 31, 2023 2022 Software $ 19,000 $ 32,000 Service 3,000 - Total revenue $ 22,000 $ 32,000 Fair Value of Financial Instruments The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of March 31, 2023 and December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $265,000 and $112,000, respectively (see Note 8). Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Stock-Based Compensation The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. Loss per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Three Months Ended March 31, 2023 2022 Options to purchase common stock 150,633,000 83,133,001 Warrants to purchase common stock 476,049,076 68,981,234 Convertible notes 101,745,573 21 Convertible Series B Preferred stock 1,255,638 1,284,394 Total 729,683,287 153,398,650 Concentrations For the three months ended March 31, 2023, sales to two customers comprised 40% and 35% of revenues. For the three months ended March 31, 2022, sales to four customers comprised 40%, 35%, 17% and 4% of revenues. At March 31, 2023, only two customers comprised more than 10% of accounts receivable. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At March 31, 2023, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. Segments The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.	Note 1 – Organization and Summary of Significant Accounting Policies Zerify, Inc. (formerly known as StrikeForce Technologies, Inc.) (the “Company”), a software development and services company, offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey. On April 26, 2022, the Company applied for the Zerify trademark, ZERIFY™, which is intended to cover the categories of: · downloadable or recorded computer software for encryption; · downloadable or recorded computer software for cyber security assessment and protection; · anti-spyware software; downloadable or recorded computer application software for mobile devices, namely, software for protecting people from identity theft; · downloadable or recorded computer software for guarding users of computers and remote access devices from identity theft, featuring various software tools, namely, anti-keyboard logger and keyboard stroke encryption. On June 14, 2022, the Company’s Board of Directors and by consent majority shareholder vote approved changing the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc. The name change was made to better reflect the Company’s business plans centered around its cyber security software products. On August 1, 2022, FINRA approved the Company’s Common Stock being quoted on the OTCQB Market under the symbol “ZRFY”, however, on January 19, 2023 we became quoted on the OTC Markets Pink as a result of our common stock being quoted below $0.01. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and had a stockholders’ deficit of $14,855,000. Additionally, at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing. Basis of presentation and principles of consolidation The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers. BST meets the definition of a variable interest entity (“VIE”) because the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors. COVID-19 In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and disrupted normal business operations. The outbreak could adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations. During the years ended December 31, 2022 and 2021, the COVID-19 pandemic did negatively impact the Company’s operating results. For the years ended December 31, 2022, and 2021, the Company’s sales decreased by 47%, compared to the prior year, however, there have not been any impairments of the Company’s assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. Revenue Recognition The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Years Ended December 31, 2022 2021 Software $ 96,000 $ 193,000 Service 7,000 - Total revenue $ 103,000 $ 193,000 Accounts Receivable Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively. Property and Equipment Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows: Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7 Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment. Impairment of Long-lived Assets The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets. Income Taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Leases The Company leases its corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). Fair Value of Financial Instruments The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9). Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Stock-Based Compensation The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. Loss per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Years Ended December 31, 2022 2021 Options to purchase common stock 150,633,001 83,133,001 Warrants to purchase common stock 362,729,077 68,981,234 Convertible notes 29,450,564 21 Convertible Series B Preferred stock 1,255,638 1,255,638 Total 544,068,280 153,369,894 Advertising, Sales and Marketing Costs Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively. Research and Development Costs Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively. Concentrations For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. Segments The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2022
Property and Equipment
Property and Equipment	Note 2 – Property and Equipment Property and equipment, stated at cost, less accumulated depreciation consisted of the following: December 31, 2022 December 31, 2021 Computer equipment $ 84,000 $ 82,000 Computer software 45,000 44,000 Furniture and fixtures 46,000 10,000 Office equipment 17,000 17,000 192,000 153,000 Less accumulated depreciation (156,000 ) (153,000 ) $ 36,000 $ - Depreciation expense for the years ended December 31, 2022 and 2021 was $3,000 and $4,000, respectively.

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Convertible Notes Payable
Convertible Notes Payable	Note 2 – Convertible Notes Payable Convertible notes payable consisted of the following: March 31, 2023 December 31, 2022 Unsecured (a) Convertible notes due to AL-Bank $ 373,000 $ 383,000 (b) Convertible note with Diagonal Lending 254,000 100,000 Unsecured (c) Convertible notes with fixed conversion features, in default 895,000 895,000 Convertible notes payable 1,522,000 1,378,000 Less debt discount (204,000 ) (96,000 ) Total Convertible notes payable $ 1,318,000 $ 1,282,000 (a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in prior fiscal years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a Denmark based financing institution. In September 2021, the Company executed a repayment agreement with AL-Bank requiring the Company to make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in March 2025, for a total of $400,000. Once the payments are made in full pursuant to the repayment agreement, the remaining balance of $143,000 will be forgiven and will be accounted for at that time. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $383,000. During the three months ended March 31, 2023, the Company made principal payments of $10,000. At March 31, 2023, the outstanding balance of the unsecured convertible notes payable amounted to $373,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock. (b) On December 15, 2022, the Company issued a convertible note payable to 1800 Diagonal Lending LLC (“Diagonal Lending”) for $100,000. The note is unsecured, bears interest at a rate of 12%, or 22% on default, is due on December 15, 2023, and has a repayment penalty of 120% of the unpaid principal and unpaid interest if prepaid within 180 days of December 15, 2022. The convertible note payable is convertible into shares of the Company’s common stock at a conversion price of 65% of the two lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the 15 trading days immediately preceding the conversion date. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $100,000. On January 19, 2023, February 6, 2023, and March 4, 2023, the Company issued additional convertible notes payable to Diagonal Lending for $45,000, $55,000, and $54,000, on comparable terms, respectively. At March 31, 2023, the outstanding balance of the unsecured convertible notes payable amounted to $254,000. The convertible notes payable, including accrued interest, are convertible to approximately 101,745,558 shares of the Company’s common stock. As the ultimate determination of shares of common stock to be issued upon conversion of these debentures can exceed the current number of available authorized shares, the Company determined that the conversion features of these debentures are not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as a derivative liability (see Note 8). During the three months ended March 31, 2023, of the incurred derivative liability of $175,000 related to the conversion feature of the debentures, $154,000 was accounted as debt discount and the remaining $21,000 as financing costs. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $96,000. During the three months ended March 31,2023, $154,000 was added related to the convertible notes issued during the period, and $46,000 was recorded to interest expense. As of March 31, 2023, the unamortized debt discount was $204,000. (c) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior fiscal years. At March 31, 2023 and December 31, 2022, the outstanding balance of unsecured convertible notes payable amounted to $895,000 and $895,000, respectively, and are deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.	Note 3 – Convertible Notes Payable Convertible notes payable consisted of the following: December 31, 2022 December 31, 2021 Unsecured (a) Convertible notes due to AL-Bank $ 383,000 $ 503,000 (b) Convertible note with Diagonal Lending 100,000 - Unsecured (c) Convertible notes with fixed conversion features, in default 895,000 895,000 Convertible notes payable 1,378,000 1,398,000 Less debt discount (96,000 ) - Total Convertible notes payable $ 1,282,000 $ 1,398,000 (a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in prior fiscal years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a Denmark based financing institution. In September 2021, the Company executed a repayment agreement with AL-Bank requiring the Company to make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in March 2025 (see Note 15), for a total of $400,000. Once the payments are made in full pursuant to the repayment agreement, the remaining balance of $143,000 will be forgiven and will be accounted for at that time. At December 31, 2021, the outstanding balance of convertible notes payable amounted to $503,000. During the year ended December 31, 2022, the Company made principal payments of $120,000. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $383,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock. (b) On December 15, 2022, the Company issued a convertible note payable to 1800 Diagonal Lending LLC (“Diagonal Lending”) for $100,000. The note is unsecured, bears interest at a rate of 12%, or 22% on default, is due on December 15, 2023, and has a repayment penalty of 120% of the unpaid principal and unpaid interest if prepaid within 180 days of December 15, 2022. The convertible note payable is convertible into shares of the Company’s common stock at a conversion price of 65% of the two lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the 15 trading days immediately preceding the conversion date. As the ultimate determination of shares of common stock to be issued upon conversion of these debentures can exceed the current number of available authorized shares, the Company determined that the conversion features of these debentures are not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as a derivative liability (see Note 9). Of the incurred derivative liability of $164,000 related to the conversion feature of the debentures, $100,000 was accounted as debt discount and the remaining $64,000 as financing costs. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $96,000. The convertible notes payable, including accrued interest are convertible to approximately 29,450,549 shares of the Company’s common stock. (c) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior fiscal years. At December 31, 2022 and December 31, 2021, the outstanding balance of unsecured convertible notes payable amounted to $895,000 and $895,000, respectively, and are deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.

Convertible Notes Payable Relat

Convertible Notes Payable Related Parties	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Convertible Notes Payable Related Parties
Convertable Notes Payable - Related Parties	Note 3 – Convertible Notes Payable – Related Parties In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2023, as amended. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of March 31, 2023 and December 31, 2022, the outstanding balance of the notes payable amounted to $268,000.	Note 4 – Convertible Notes Payable – Related Parties In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2023, as amended. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $268,000.

Notes Payable

Notes Payable	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Notes Payable
Notes Payable	Note 4 – Notes Payable Notes payable consisted of the following: March 31, 2023 December 31, 2022 Unsecured (a) Notes payable - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 286,000 286,000 (c) Note payable - EID loan 148,000 149,000 Secured (d) Notes payable – October 2022 1,000,000 1,000,000 (e) Notes payable - in default 6,000 6,000 (f) Notes payable – July 2022 165,000 211,000 Total notes payable principal outstanding 3,244,000 3,291,000 Less debt discount (136,000 ) (323,000 ) Total notes payable 3,108,000 2,968,000 Less current portion of notes payable, net of discount (2,966,000 ) (2,826,000 ) Long term notes payable $ 142,000 $ 142,000 (a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At March 31, 2023 and December 31, 2022, the outstanding balance of the notes payable was $1,639,000, respectively, and are in default. (b) In 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2021, the outstanding balance of the notes payable amounted to $310,000. During the year ended December 31, 2022, the Company made principal payments of $24,000. At December 31, 2022 and March 31, 2023 the outstanding balance of the BlockSafe notes payable amounted to $286,000, and are in default. (c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA) under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month were deferred for twenty-four months and commenced in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type. As of December 31, 2022, the outstanding balance of the EID loan amounted to $149,000. During the three months ended March 31, 2023, the Company made principal payments of $1,000. At March 31, 2023, the outstanding balance of the EID loan amounted to $148,000. The Company was in compliance with the terms of the EID loan as of March 31, 2023. (d) On October 26, 2022, the Company entered into a Securities Purchase Agreement with Walleye Opportunities Master Fund Ltd., a Cayman Islands company (“Walleye”), whereby Walleye purchased a promissory note of the Company, in the aggregate principal amount of One Million Dollars ($1,000,000) (the “Note”), which is convertible by Walleye into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) upon an Event of Default . On the Closing Date (specifically October 26, 2022), the Company received $800,000 which represented the principal of $1,000,000 less an original issue discount in the amount of $200,000 paid to Walleye. Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum. The Company shall have the right, exercisable on seven (7) Trading Days prior written notice to Walleye, to prepay the outstanding Principal Amount then due under this Note prior to any default. Walleye may demand immediate repayment in the event of certain events, including a financing event. In the event of default, Walleye shall have, as of and after any event of default, the option to cover the outstanding obligation of the Note at 90% of the lowest VWAP of the Common Stock on the date of the applicable conversion (the “Conversion Date”) or at any point during the four (4) Trading Day period immediately prior to the date of the applicable conversion. In addition, on the Closing Date, Walleye received a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.0045 per share which shall be earned in full as of the Closing Date of October 26, 2022. The common stock purchase warrant has a cashless exercise provision (unless there is a registration statement registering the underlying shares to the common stock purchase warrants). As a result of these issuances and grants, the Company incurred the following (a) relative fair value of the warrants granted of $260,000; and (b) original issue discounts of $200,000 of the debentures for a total of $460,000 which was allocated as debt discount. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $323,000. During the three-month ended March 31, 2023, the Company recorded $187,000 as interest expense, leaving an unamortized debt discount balance of $136,000 at March 31, 2023. From October 26, 2022 until the Note is extinguished in its entirety, Walleye shall receive a right of participation and first right of refusal on subsequent financings as described in the Agreement. On October 26, 2022, through a Security Agreement of the same date, the Company’s Subsidiaries (specifically BlockSafe Technologies, Inc. and Cyber Security Risk Solutions, LLC) agreed to guarantee and act as surety for payment of the Note. At March 31, 2023 and December 31, 2022, the outstanding balance of the note payable was $1,000,000, respectively. (e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 37% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one unsecured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At March 31, 2023 and December 31, 2022, the outstanding balance of the secured notes payable was $6,000 and $6,000, respectively, and is in default. (f) In July 2022, the Company issued notes payable aggregating $275,000. The notes bear an average interest rate of 51% per annum, each agreement secured by substantially all of the assets of the Company and maturing in January 2024. At December 31, 2022, the outstanding balance of the secured notes payable was $211,000. During the three months ended March 31, 2023, the Company made principal payments of $46,000. At March 31, 2023, the outstanding balance of the secured notes payable was $165,000.	Note 5 – Notes Payable Notes payable consisted of the following: December 31, 2022 December 31, 2021 Unsecured (a) Notes payable- $1,639,000 - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 286,000 310,000 (c) Note payable-EID loan 149,000 150,000 Secured (d) Notes payable – October 2022 1,000,000 - (e) Notes payable - in default 6,000 23,000 (f) Notes payable – July 2022 211,000 - Total notes payable principal outstanding 3,291,000 2,122,000 Less debt discount (323,000 ) - Total notes payable 2,968,000 2,122,000 Less current portion of notes payable, net of discount (2,826,000 ) (1,972,000 ) Long term notes payable $ 142,000 $ 150,000 (a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable was $1,639,000, respectively, and are in default. (b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2022, the outstanding balance of the notes payable amounted to $310,000. During the year ended December 31, 2022, the Company made principal payments of $24,000. At December 31, 2022, the outstanding balance of the BlockSafe notes payable amounted to $286,000, and are in default. (c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA)under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty-four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type. During the year ended December 31, 2022, the Company made principal payments of $1,000. At December 31, 2022 and 2021, the outstanding balance of the EID loan amounted to $149,000 and $150,000, respectively. The Company was in compliance with the terms of the EID loan as of December 31, 2022. (d) On October 26, 2022, the Company entered into a Securities Purchase Agreement with Walleye Opportunities Master Fund Ltd., a Cayman Islands company (“Walleye”), whereby Walleye purchased a promissory note of the Company, in the aggregate principal amount of One Million Dollars ($1,000,000) (the “Note”), which is convertible by Walleye into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) upon an Event of Default . On the Closing Date (specifically October 26, 2022), the Company received $800,000 which represented the principal of $1,000,000 less an original issue discount in the amount of $200,000 paid to Walleye. Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum. The Company shall have the right, exercisable on seven (7) Trading Days prior written notice to Walleye, to prepay the outstanding Principal Amount then due under this Note prior to any default. Walleye may demand immediate repayment in the event of certain events, including a financing. In the event of default, Walleye shall have, as of and after any event of default, the option to cover the outstanding obligation of the Note time 120% at 90% of the lowest VWAP of the Common Stock on the date of the applicable conversion (the “Conversion Date”) or at any point during the four (4) Trading Day period immediately prior to the date of the applicable conversion. In addition, on the Closing Date, Walleye received a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share which shall be earned in full as of the Closing Date of October 26, 2022. The common stock purchase warrant has a cashless exercise provision (unless there is a registration statement registering the underlying shares to the common stock purchase warrants). As a result of these issuances and grants, the Company incurred the following (a) relative fair value of the warrants granted of $260,000; and (b) original issue discounts of $200,000 of the debentures for a total of $460,000 which was allocated as debt discount. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $323,000. From October 26, 2022 until the Note is extinguished in its entirety, Walleye shall receive a right of participation and first right of refusal on subsequent financings as described in the Agreement. On October 26, 2022, through a Security Agreement of the same date, the Company’s Subsidiaries (specifically BlockSafe Technologies, Inc. and Cyber Security Risk Solutions, LLC) agreed to guarantee and act as surety for payment of the Note. At December 31, 2022, the outstanding balance of the note payable was $1,000,000. (e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 37% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one unsecured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2021, the outstanding balance of the unsecured note agreements was $23,000. During the year ended December 31, 2022, the Company made principal payments of $17,000. At December 31, 2022, the outstanding balance of the secured notes payable was $6,000 and is in default. (f) In July 2022, the Company issued notes payable aggregating $275,000. The notes bear average interest rate of 51% per annum, each agreement secured by substantially all of the assets of the Company and maturing in January 2024. During the year ended December 31, 2022, the Company made principal payments of $64,000. At December 31, 2022, the outstanding balance of the secured notes payable was $211,000.

Notes Payable Related Parties

Notes Payable Related Parties	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Notes Payable Related Parties
Notes Payable - Related Parties	Note 5 – Notes Payable – Related Party Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2023, as amended. The outstanding balance of these notes payable at March 31, 2023 and December 31, 2022 amounted to $693,000.	Note 6 – Notes Payable – Related Party Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2023, as amended. The outstanding balance of these notes payable at December 31, 2022 and December 31, 2021 amounted to $693,000.

VIE Financing Obligation

VIE Financing Obligation	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
VIE Financing Obligation
VIE Financing Obligation	Note 6 – VIE Financing Obligation The Company is in the process of developing Coins or Tokens which are envisioned as virtual currency. In fiscal 2018, the Company’s consolidated subsidiary, BlockSafe, issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined by promissory notes and subscription agreements that would be controlling with respect to any offer or sale of tokens to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000. During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe. At March 31, 2023 and December 31, 2022, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens. At March 31, 2023 and through the date of filing, BlockSafe has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At March 31, 2023, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe, through the issuance of tokens, or through other means if tokens are never issued.	Note 7 – VIE Financing Obligation The Company is in the process of developing Coins or Tokens which are envisioned as virtual currency. In fiscal 2018, the Company’s consolidated subsidiary, BlockSafe, issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined by promissory notes and subscription agreements that would be controlling with respect to any offer or sale of tokens to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000. During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe. At December 31, 2022 and December 31, 2021, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens. At December 31, 2022 and through the date of filing, BlockSafe has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At December 31, 2022, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe, through the issuance of tokens, or through other means if tokens are never issued.

Contingent Payment Obligation

Contingent Payment Obligation	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Contingent Payment Obligation
Contingent Payment Obligation	Note 7 – Contingent Payment Obligation On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”) for financing of $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against alleged infringements of its patents. In exchange for the financing, the Funders are entitled to receive (after the payment of legal fees), the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter. The Funders are to be paid only if the Company achieves recoveries of claim proceeds. At March 31, 2023 and December 31, 2022, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if patent enforced claim proceeds are recovered.	Note 8 – Contingent Payment Obligation On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”) for financing of $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against alleged infringements of its patents. In exchange for the financing, the Funders are entitled to receive( after the payment of legal fees), the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter. The Funders are to be paid only if the Company achieves recoveries of claim proceeds. At December 31, 2022 and 2021, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if patent enforced claim proceeds are recovered.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Derivative Financial Instruments
Derivative Financial Instruments	Note 8 – Derivative Financial Instruments The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The Company has issued convertible debentures, and in accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. The derivative liabilities were valued using the Binomial pricing model and/or Black Scholes pricing model with the following assumptions: At March 31, 2023 Issued 2023 At December 31, 2022 Stock Price $ 0.0026 $ 0.0054 $ 0.0055 Exercise Price $ 0.0034 $ 0.0034 $ 0.0034 Expected Life (Years) 0.79 1.00 0.80 Volatility 163 % 162 % 165 % Dividend Yield 0 % 0 % 0 % Risk-Free Interest Rate 4.64 % 4.84 % 4.73 % Fair value: Conversion feature $ 265,000 $ 175,000 $ 112,000 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future. At December 31, 2022, the balance of the derivative liabilities was $112,000. During the three months ended March 31, 2023, the Company recognized derivative liabilities of $175,000 upon issuance of additional secured convertible debentures (see Note 2). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability on March 31, 2023 was $265,000, and as a result, recorded a change in fair value of $22,000 as a component of other income and expenses in the consolidated statements of operations.	Note 9 – Derivative Financial Instruments The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. During fiscal year 2022, the Company issued convertible debentures, and in accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of December 31, 2022, the derivative liabilities were valued using the Binomial pricing model and/or Black Scholes pricing model with the following assumptions: At December 31, 2022 Issued December 15, 2022 At December 31, 2021 Stock Price $ 0.0055 $ 0.0075 $ - Exercise Price $ 0.0034 $ 0.0034 $ - Expected Life (Years) 0.80 0.84 - Volatility 165 % 159 % - % Dividend Yield 0 % 0 % - % Risk-Free Interest Rate 4.73 % 4.65 % - % Fair value: Conversion feature $ 112,000 $ 164,000 $ - The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future. At December 31, 2020, the balance of the derivative liabilities was $163,000. During the year ended December 31, 2021, the corresponding convertible notes payable were converted to equity. Pursuant to current accounting guidelines, the Company determined the final fair value of the derivative liability which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At December 31, 2021, the Company has no more instruments accounted as derivative liabilities. On December 15, 2022, the Company recognized derivative liabilities of $164,000 upon issuance of additional secured convertible debentures (see Note 5). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability on December 31, 2022 was $112,000, and as a result, recorded a change in fair value of $52,000 as a component of other income and expenses in the consolidated statements of operations. At December 31, 2022, the balance of the derivative liabilities was $112,000.

Operating Lease

Operating Lease	6 Months Ended
	Jun. 30, 2021
Operating Lease
Operating Lease	Note 10 – Operating Lease In January 2019, the Company entered into a noncancelable operating lease for its office headquarters requiring payments of approximately $5,000 per month, payments increasing 3% each year, and ending on January 31, 2024. The Company determines if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: Year ended December 31, 2022 Year ended December 31, 2021 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 61,000 $ 56,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021 $ 58,000 $ 55,000 Weighted average remaining lease term – operating leases (in years) 1.1 2.1 Average discount rate – operating leases 10.0 % 10.0 % The supplemental balance sheet information related to leases for the period is as follows: At December 31, 2022 Operating leases Long-term right-of-use assets $ 54,000 Short-term operating lease liabilities $ 56,000 Long-term operating lease liabilities 1,000 Total operating lease liabilities $ 57,000 Maturities of the Company’s lease liabilities are as follows: Year Ending Operating Leases 2023 58,000 2024 - Total lease payments 58,000 Less: Imputed interest/present value discount (1,000 ) Present value of lease liabilities $ 57,000 Lease expenses were $61,000 and $56,000 during the years ended December 31, 2022 and 2021, respectively.

Stockholders Deficit

Stockholders Deficit	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Stockholders Deficit
Stockholders' Deficit	Note 9 - Stockholders’ Deficit Common Stock During the three months ended March 31, 2023, pursuant to the Company’s Qualified Regulation A Offering, the Company issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. Warrants The table below summarizes the Company’s warrant activities for the three months ended March 31, 2023: Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2023 362,729,077 $ 0.0045-0.75 $ 0.006 Granted 113,319,999 0.02 0.02 Canceled/Expired - - - Exercised - - - Balance outstanding and exercisable, March 31, 2023 476,049,076 $ 0.0045 – 0.75 $ 0.009 At March 31, 2023, the warrants had no intrinsic value. The following table summarizes information concerning outstanding and exercisable warrants as of March 31, 2023: Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 346,666,653 4.47 $ 0.0045 0.02 124,339,999 4.90 0.02 0.05 5,000,000 3.48 0.50 0.75 42,424 1.68 0.75 $ 0.0045 - $0.75 476,049,076 4.46 $ 0.009 During the three months ended March 31, 2023, pursuant to our private placement under Rule 506(b) of Regulation D, the Company sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share, and expire in five years.	Note 11 – Stockholders’ Deficit Preferred Stock On October 21, 2010, the Company amended its Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10, the designations, rights, and preferences to be determined by the Board of Directors. On November 15, 2010, the Company changed its domicile from the State of New Jersey to the State of Wyoming. In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation. The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding. The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock is convertible into a number of common stock shares equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange. In February 2014, the Company’s Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time the Company receives a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to the Company’s common stock, the minimum price discount floor level is set at $0.005, as decided by the Company’s Board of Directors. Series A Preferred Stock In 2011, the Company issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in the aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of the total issued and outstanding shares of the Company’s common stock. This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to the shareholders of the Company. The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued. At December 31, 2022 and 2021, there were 3 shares of Series A Preferred Stock outstanding. There were no issuances of Series A Preferred stock during fiscal 2022 and 2021. Series B Preferred Stock The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange. At December 31, 2022 and 2021, there were 36,667 shares of Series B Preferred Stock outstanding. There were no issuances of Series B Preferred stock during fiscal 2022 and 2021. Common Stock Sale of Common Stock During the year ended December 31, 2022, pursuant to the Company’s Qualified Regulation A Offering, the Company issued 40,100,000 common stock shares in exchange for cash of $180,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and its placement agent to purchase 8,020,000 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. During the year ended December 31, 2021, pursuant to the Company’s offering under Regulation A, the Company issued 119,666,450 shares of common stock in exchange for cash of $5,368,000, net of direct fees and commission. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 55 million shares of common stock. The warrants are fully vested, exercisable at $0.05 per share and will expire in five years. Common Stock Issued for Services During the year ended December 31, 2022, the Company issued 30,105,936 shares of its common stock for services, with a fair value of $423,000. The common shares were valued at the respective date of issuance. Included in this issuance were 2,500,000 and 10,000,000 shares issued to New to the Street in June and August of 2022 for services relating to a consulting agreement and were determined to have a fair value of $56,000 and $127,000, respectively. During the year ended December 31, 2021, the Company issued 3,365,138 shares of its common stock for services, with a fair value of $181,000. The common stock shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission. Common Stock Issued on Conversion of Notes Payable and Accrued Interest During the year ended December 31, 2021, the Company issued 16,168,589 shares of common stock with a fair value of $1,035,000 upon conversion of convertible notes payable and accrued interest. Common Stock Issued on Settlement of Debt During the year ended December 31, 2021, the Company issued 460,829 shares of common stock with a fair value of $88,000 as debt settlement. Repurchase of common stock and warrants In May 2022, the Company repurchased 16,168,589 shares of common stock and 605,476 shares of warrants from an investor for $165,000. All shares repurchased by the Company were retired immediately upon acquisition. As of December 31, 2022, there are no shares held in treasury. Warrants The table below summarizes the Company’s warrant activities for the years ended December 31, 2021 and 2022: Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 27,405,475 $ 0.0045-2.90 $ 0.0117 Granted 55,000,000 0.05 0.05 Canceled/Expired - - - Exercised (13,424,241 ) - - Balance, January 1, 2021 68,981,234 0.0045-2.90 0.0421 Granted 394,353,319 0.0045 – 0.05 0.011 Canceled/Expired (605,476 ) 0.0085 – 2.90 0.035 Exercised (100,000,000 ) 0.08 – 2.90 0.165 Balance, December 31, 2022 362,729,077 $ 0.0045 – 0.75 $ 0.006 Balance outstanding and exercisable, December 31, 2022 362,729,077 $ 0.0045 – 0.75 $ 0.006 At December 31, 2022 and 2021, the intrinsic value of the warrants amounted to $13,000 and $473,000, respectively. The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2022: Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 333,333,319 4.79 $ 0.0045 0.005 13,333,334 2.87 $ 0.005 0.02 11,020,000 4.85 0.02 0.05 5,000,000 3.72 0.50 0.75 42,424 1.93 0.75 $ 0.0045 - $0.75 362,729,077 4.05 $ 0.006 Exercise of Warrants During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,334 warrant shares were exercised on a cashless basis in exchange for 12,349,726 common stock shares. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost. Modification, Exercise and Grant of Warrants On May 5, 2022, the Company entered into an Inducement Offer to Exercise Common Stock Purchase Warrants Letter Agreements (the “Exercise Agreements”) with certain of the holders of the Existing Warrants, the Special Equities Opportunity Fund, LLC and Gregory Castaldo, to exercise existing warrants to purchase an aggregate of 50,000,000 shares of Common Stock (the “Exercising Holders”). Pursuant to the Exercise Agreements, the Exercising Holders and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holders would exercise their Existing Warrants (the “Investor Warrants”) for shares of Common Stock underlying such Existing Warrants (the “Exercised Shares”) at a reduced exercise price of $0.02 per share of Common Stock. In order to induce the Exercising Holders to cash exercise the Investor Warrants, the Exercise Agreements provide for the issuance of new warrants to purchase up to an aggregate of 50,000,000 shares of Common Stock (the “New Warrants”), with such New Warrants to be issued in an amount equal to the number of the Exercised Shares underlying any Investor Warrants. The New Warrants are exercisable after issuance, provide for a cashless exercise provision if the shares of Common Stock underlying the New Warrants are not registered and terminate on the date that is five years following the issuance of the New Warrants. The New Warrants have an exercise price per share of $0.05. The New Warrants and the shares of Common Stock issuable upon the exercise of the New Warrants are not being registered under the Securities Act of 1933 and are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act of 1933. The Exercised Shares are registered for resale on effective registration statements previously filed with the Securities and Exchange Commission. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $940,000, net of direct fees and commission. In August 2022, the Company modified the exercise price of the warrants granted to the two investors/warrant holders in May 2022 from $0.05 per share to $0.01 per share. As a result of this modification, the warrant holders exercised 50,000,000 shares of warrants and the Company received $500,000 in cash and issued 50,000,000 shares of common stock. As a result of these transactions, the Company issued a total of 100 million shares of common stock and received cash of $1,440,000, net of direct costs. Deemed Dividend to Warrant Holders During the year ended December 31, 2022, the Company granted an aggregate of 150,000,000 warrants for services and financing activities that contained a provision requiring the Company to adjust the terms of the warrants when future financing events occur on more favorable terms. On December 21, 2022, and pursuant to the beneficial terms contained in the Company’s Qualified Regulation A Offering, the Company modified the 150,000,000 warrants by granting an additional 183,333,320 warrants and adjusting the warrant exercise from price from $0.01 per share to $0.0045 per share. Pursuant to current accounting guidelines, the Company recorded the incremental fair value of $1,787,000 as a deemed dividend. Grant of Warrants for Services On July 1, 2022, the Company granted warrants to a consultant, to purchase 3,000,000 shares of common stock for financing services rendered. The warrants are fully vested, exercisable at of $0.02 per share, will expire in 5 years and with an estimated fair value $63,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below: Assumptions Exercise Price $ 0.02 Share Price $ 0.02 Volatility % 233 % Risk Free Rate 2.88 % Expected Term (yrs.) 5 Dividend Rate 0 % On October 21, 2022, the Company granted warrants pursuant to a Financial Advisory Agreement, to purchase 50,000,000 shares of common stock for advisory services rendered. The warrants are fully vested, exercisable at of $0.01 per share, will expire in 5 years and with an estimated fair value $372,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below: Assumptions Exercise Price $ 0.01 Share Price $ 0.00752 Volatility % 224 % Risk Free Rate 4.34 % Expected Term (yrs.) 5 Dividend Rate 0 % During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost. Grants of Warrants on Issuance of Note Payable Included in the issuance of a Note Payable to Walleye dated October 26, 2022 (see Note 5), Walleye received a grant of a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share, which shall be earned in full as of October 26, 2022. The estimated relative fair value of the warrants was determined to be $260,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below: Assumptions Exercise Price $ 0.01 Share Price $ 0.0079 Volatility % 268 % Risk Free Rate 4.41 % Expected Term (yrs.) 5 Dividend Rate 0 %

Stock Options

Stock Options	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Stock Options
Stock Options	Note 10 – Stock Options The table below summarizes the Company’s stock option activities for the three months ended March 31, 2023: Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2023 150,633,001 $ 0.0045- 1,121,250,000 $ 0.0307 Granted - - - Exercised (1 ) $ 1,121,250,000 1,121,250,000 Expired - - - Balance outstanding, March 31, 2023 150,633,000 $ 0.0045-3.00 $ 0.0306 Balance exercisable, March 31, 2023 120,591,791 $ 0.0045-3.00 $ 0.0371 The following table summarizes information concerning the Company’s stock options as of March 31, 2023: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 3.0000 518,000 3.80 $ 3.0000 518,000 3.80 $ 3.000 2.0000 115,000 6.72 2.0000 115,000 6.72 2.0000 0.0375 65,000,000 8.73 0.0375 65,000,000 8.73 0.0375 0.005 17,500,000 7.84 0.0050 17,500,000 7.84 0.0050 0.0045 67,500,000 9.72 0.0045 37,458,791 9.97 0.0045 $ 0.0045 – 3.000 150,633,000 6.18 $ 0.0307 120,591,791 6.18 $ 0.0371 At March 31, 2023 and December 31, 2022, the intrinsic value of outstanding options was $0 and $76,000, respectively.	Note 12 – Stock Options In November 2012, the stockholders approved the 2012 Stock Option Plan for the Company’s employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000 and was increased to 400,000,000 in November 2017 by unanimous consent of the Board of Directors. The table below summarizes the Company’s stock option activities for the years ended December 31, 2021 and 2022: Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 58,133,001 $ 0.005-1,121,250,000 $ 0.03704 Granted 67,500,000 0.005-0.0375 0.0104 Exercised (42,500,000 ) - - Expired - - - Balance, December 31, 2021 83,133,001 0.005-1,121,250,000 0.0274 Granted 67,500,000 0.0045 0.0045 Exercised - - - Expired - - - Balance outstanding, December 31, 2022 150,633,001 $ 0.0045-1,121,250,000 $ 0.0307 Balance exercisable, December 31, 2022 87,212,671 $ 0.0045-1,121,250,000 $ 0.0497 The following table summarizes information concerning the Company’s stock options as of December 31, 2022: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 0.01 $ 1,121,250,000 1 0.01 $ 1,121,250,000 3.0000 518,000 4.04 3.0000 518,000 4.04 3.0000 2.0000 115,000 6.97 2.0000 115,000 6.97 2.0000 0.0375 65,000,000 8.98 0.0375 65,000,000 8.98 0.0375 0.005 17,500,000 8.08 0.0050 17,500,000 8.08 0.0050 0.0045 67,500,000 9.97 0.0045 4,079,670 9.97 0.0045 $ 0.0045 – 1,121,250,000 150,633,001 6.43 $ 0.0307 87,212,671 6.43 $ 0.0497 At December 31, 2022 and 2021, the intrinsic value of outstanding options was $76,000 and $3,225,000, respectively. During the year ended December 31, 2022, the Company recorded an additional stock compensation expense of $2,958,000 to account for options granted in the prior year that vested. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.0045 per share, vest over six months, and expire in 10 years, with a total fair value of approximately $594,000. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 394%, (ii) discount rate of 3.79%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $32,000 to account for the fair value of options that vested during the period. As of December 31, 2022, the unamortized stock compensation amounted to approximately $562,000 which will be recognized in fiscal 2023. During the year ended December 31, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company issued 39,955,655 shares of the Company’s common stock upon cashless exercise of 42,500,000 options. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share for 2,500,000 option shares and $0.0375 for 65,000,000 option shares, vest over six months, and expire in 10 years, with a total fair value of approximately $5,400,000 using the Black-Scholes Merton Option Pricing model. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 137%, (ii) discount rate of 1.46%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $368,000 to account for the fair value of options that vested during the period. In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense.

Income Tax Provision

Income Tax Provision	12 Months Ended
	Dec. 31, 2022
Income Tax Provision
Income Tax Provision	Note 13 – Income Tax Provision A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows for the year ended: December 31, 2022 December 31, 2021 Federal statutory income tax rate 21.0 % 21.0 % State tax, net of federal benefit 7.0 % 5.0 % Change in valuation allowance on net operating loss carry-forwards (28.0 ) (26.0 ) Effective income tax rate 0.0 % 0.0 % Deferred tax assets consist of the following: December 31, 2022 December 31, 2021 Net deferred tax assets: Stock-based compensation $ 3,776,000 $ 702,000 Private placement costs 394,000 366,000 Operating lease liability 16,000 42,000 Loss on extinguishment of debt 1,858,000 1,697,000 Net operating loss carryforwards 7,362,000 5,946,000 Deferred tax assets 13,406,000 8,753,000 Less valuation allowance (13,406,000 ) (8,753,000 ) Total - - The provisions of ASC Topic 740, Accounting for Income Taxes, require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2022 and 2021, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was more likely than not that the net deferred tax assets were not fully realizable. Accordingly, the Company established a full valuation allowance against its net deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance. At December 31, 2022 and 2021, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal NOL purposes approximately $30.2 million and $26.5 million was available at December 31, 2022 and 2021. For state NOL purposes approximately $14.7 million and $13.2 million was available at December 31, 2022 and 2021, respectively. The Federal carryforwards expire on various dates through 2041 and the state carryforwards expire through 2041. Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation. The Company’s operations are based in New Jersey and it is subject to Federal and New Jersey state income tax. Tax years after 2016 are open to examination by United States and state tax authorities. The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. ASC 740 also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions. As of December 31, 2022 and 2021, no liability for unrecognized tax benefits was required to be recorded or disclosed.

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Commitment and Contingencies
Commitment and Contingencies	Note 11 – Commitment and Contingencies Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”), filed a stockholder derivative Complaint against the Company’s directors, Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their management of the Company. Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint. On March 10, 2023, the Defendants served a motion to dismiss the complaint upon the Plaintiff. The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023. Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation. Onstream Media Corporation The Company is currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases. The cases and their filing dates follow: Case Date Filed Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00191 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00192 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00193 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00194 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00195 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00196 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00197 (DWY) September 9, 2022 Subsequent to March 31, 2023, with respect to the Onstream Media Corporation v. Zerify, Inc. litigation specified immediately above, effective as of April 26, 2023, the parties entered into a Patent License Agreement and the Court dismissed all cases pertaining to the Onstream Media Corporation v. Zerify litigation.	Note 14 – Commitment and Contingencies Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant (U.S. District Court, District of New Jersey, Civil Action No. 2:22-cv-07258-MCA-AME On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”), filed a stockholder derivative Complaint against our directors, Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their management of us. Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint. On March 10, 2023, the Defendants served a motion to dismiss the complaint upon the Plaintiff. The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023. Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation. Onstream Media Corporation We are currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases. The cases and their filing dates follow: Case Date Filed Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00191 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00192 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00193 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00194 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00195 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00196 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00197 (DWY) September 9, 2022

Subsequent Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Subsequent Events
Subsequent Events	Note 12 – Subsequent Events On May 2, 2023, The Company issued Supplemental No. 1 dated May 2, 2023 to the Offering Circular qualified on December 31, 2022. The Company elected to affect the Qualified Offering of December 21, 2022 by: (a) reducing the Per Unit Price from $0.0225 to $0.018; and (b) reducing the per share price of each of the 5 shares from $0.0045 to $0.0036 that comprise each 1 Unit. The warrant that is also a part of each Unit as previously disclosed in the Qualified Offering remains with a $0.02 cent exercise price. The Unit Price and the Per Share Price are being made pursuant to Rule 253(g)(2) of the Securities Act of 1933, as amended (the “Securities Act’), which allows an up to 20% price change in a qualified offering statement. Subsequent to March 31, 2023, pursuant to the Company’s Qualified Regulation A Offering, the Company issued 70,000,000 shares of common stock in exchange for cash of $261,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 14,000,000 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. On April 18, 2023, the Company entered into a consulting agreement for corporate advisory services. The agreement is for a period of six months for which the Company agreed to issue 10,000,000 shares of common stock for the services. In May 2023, the Company executed a Revenue Based Financing Agreement personally guaranteed by its Chief Executive Officer in the amount of $75,000 in an arm’s length lender. The agreement becomes due and is payable daily pursuant to an Agreement for Deposits and Direct Collections. The agreement bears a specified percentage rate of 15% and has an origination fee of $1,740. In May 2023, the Company executed a Revenue Purchase Agreement personally guaranteed by its Chief Executive Officer and additionally secured by the execution of the Security Agreement and Guaranty. The amount is for $40,000 and becomes due and is payable daily pursuant to a Direct Deposit Agreement for daily deposit of $600. The agreement bears a specified purchased percentage rate of 15% and has an underwriting fee together with a program fee totaling 8%. In June 2023, the Company executed Future Receivables Sale and Purchase Agreement in the amount of $70,000.00 personally guaranteed by its Chief Executive Officer and secured by a perfected, priority lien on the assets of the Company. This agreement indicates an initial daily installment of $6,995.53 and has an underwriting fee of $14,000.00 together with a $250.00 monthly service fee. Pursuant to a Letter Agreement with Walleye Capital, the Company was notified that if its current obligation of principle and interest to Walleye goes into default as of the maturity date of September 5, 2023, and accordingly certain terms and conditions would be modified such as: -Warrants: The exercise price of the warrants will be $0.0036 and the amount of the warrants will be 138,888,889. -Subsequent Offerings: In the event of future offerings, the lender will have to be paid back in certain thresholds. In July 2023, the Company entered into a Securities Purchase Agreement in connection with the issuance of a convertible note of the Company issued to an arm’s length lender. The note has an aggregate principal amount of $50,000 and matures in July 5, 2024 and has an annual rate of interest of 12%. This note is convertible into shares of common stock upon the terms and is subject to the conditions and limitations set forth within the note. Additionally, 219,780,219 shares of common stock have been reserved through the transfer agent upon full conversion of the note. On May 23, 2023, the state of Wyoming approved an increase in the Company’s authorized common stock to ten billion (10,000,000,000) shares. On July 17, 2023, the Company issued a Securities Purchase Agreement in connection with the issuance of a convertible note payable to 1800 Diagonal Lending, LLC for $44,000.	Note 15 – Subsequent Events Subsequent to December 31, 2022, pursuant to the Company’s Qualified Regulation A Offering, the Company issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, the Company sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. On February 23, 2023, the Company entered into an amendment to the AL-Bank note (see Note 3) that relieved the Company from its previously scheduled monthly payments for March and April 2023 by extending the maturity date of the note by an additional two months, or February and March of 2025.

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization and Summary of Significant Accounting Policies
Going Concern		The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and had a stockholders’ deficit of $14,855,000. Additionally, at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.
Basis of presentation and principles of consolidation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been included. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023. These financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2022 and notes thereto contained in the Annual Report on Form 10-K of the Company as filed with the SEC on April 14, 2023. The condensed consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. The Company and BST have a management agreement pursuant to which BST shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three-year period. The management fee is eliminated in consolidation. At March 31, 2023 and December 31, 2022, the amount of VIE cash on the accompanying condensed consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.	The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers. BST meets the definition of a variable interest entity (“VIE”) because the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.
COVID-19		In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and disrupted normal business operations. The outbreak could adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations. During the years ended December 31, 2022 and 2021, the COVID-19 pandemic did negatively impact the Company’s operating results. For the years ended December 31, 2022, and 2021, the Company’s sales decreased by 47%, compared to the prior year, however, there have not been any impairments of the Company’s assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.
Use of Estimates	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary concerns, on its business and operations. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing equity instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.
Revenue Recognition	The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of the Company’s products. The following tables present our revenue disaggregated by major product and service lines: Three Months Ended March 31, 2023 2022 Software $ 19,000 $ 32,000 Service 3,000 - Total revenue $ 22,000 $ 32,000	The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Years Ended December 31, 2022 2021 Software $ 96,000 $ 193,000 Service 7,000 - Total revenue $ 103,000 $ 193,000
Accounts Receivable		Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively.
Property and Equipment		Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows: Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7 Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.
Impairment of Long-lived Assets		The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets.
Income Taxes		The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Leases		The Company leases its corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10).
Fair Value of Financial Instruments	The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of March 31, 2023 and December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $265,000 and $112,000, respectively (see Note 8).	The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9).
Derivative Financial Instruments	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Going Concern	The Company has yet to establish any history of profitable operations. During the three months ended March 31, 2023, the Company incurred a net loss of $1,669,000 and used cash in operating activities of $873,000 and at March 31, 2023, the Company had a stockholders’ deficit of $15,419,000. In addition, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report published on our December 31, 2022 year-end financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern. Management estimates that the current funds on hand will be sufficient to continue operations through the next few months. Our ability to continue as a going concern is dependent upon our ability to continue to implement our business plan. Currently, management is attempting to increase revenues by selling through a channel of new distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of its strategy to increase revenues, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution to its stockholders, in the case of equity financing.
Stock-Based Compensation	The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.	The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.
Loss per share	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Three Months Ended March 31, 2023 2022 Options to purchase common stock 150,633,000 83,133,001 Warrants to purchase common stock 476,049,076 68,981,234 Convertible notes 101,745,573 21 Convertible Series B Preferred stock 1,255,638 1,284,394 Total 729,683,287 153,398,650	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Years Ended December 31, 2022 2021 Options to purchase common stock 150,633,001 83,133,001 Warrants to purchase common stock 362,729,077 68,981,234 Convertible notes 29,450,564 21 Convertible Series B Preferred stock 1,255,638 1,255,638 Total 544,068,280 153,369,894
Advertising, Sales and Marketing Costs		Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively.
Research and Development Costs		Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively.
Concentrations	For the three months ended March 31, 2023, sales to two customers comprised 40% and 35% of revenues. For the three months ended March 31, 2022, sales to four customers comprised 40%, 35%, 17% and 4% of revenues. At March 31, 2023, only two customers comprised more than 10% of accounts receivable. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At March 31, 2023, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.	For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.
Segments	The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.	The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.
Recent Accounting Pronouncements	In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.	In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization and Summary of Significant Accounting Policies
Schedule of Revenue Recognition	Three Months Ended March 31, 2023 2022 Software $ 19,000 $ 32,000 Service 3,000 - Total revenue $ 22,000 $ 32,000	Years Ended December 31, 2022 2021 Software $ 96,000 $ 193,000 Service 7,000 - Total revenue $ 103,000 $ 193,000
Schedule of Property and Equipment		Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7
Schedule of earning per share		Years Ended December 31, 2022 2021 Options to purchase common stock 150,633,001 83,133,001 Warrants to purchase common stock 362,729,077 68,981,234 Convertible notes 29,450,564 21 Convertible Series B Preferred stock 1,255,638 1,255,638 Total 544,068,280 153,369,894
Schedule of Loss per Share	Three Months Ended March 31, 2023 2022 Options to purchase common stock 150,633,000 83,133,001 Warrants to purchase common stock 476,049,076 68,981,234 Convertible notes 101,745,573 21 Convertible Series B Preferred stock 1,255,638 1,284,394 Total 729,683,287 153,398,650

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2022
Property and Equipment
Schedule of property and equipment, stated at cost, less accumulated depreciation	December 31, 2022 December 31, 2021 Computer equipment $ 84,000 $ 82,000 Computer software 45,000 44,000 Furniture and fixtures 46,000 10,000 Office equipment 17,000 17,000 192,000 153,000 Less accumulated depreciation (156,000 ) (153,000 ) $ 36,000 $ -

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Convertible Notes Payable
Schedule of convertible notes payable	March 31, 2023 December 31, 2022 Unsecured (a) Convertible notes due to AL-Bank $ 373,000 $ 383,000 (b) Convertible note with Diagonal Lending 254,000 100,000 Unsecured (c) Convertible notes with fixed conversion features, in default 895,000 895,000 Convertible notes payable 1,522,000 1,378,000 Less debt discount (204,000 ) (96,000 ) Total Convertible notes payable $ 1,318,000 $ 1,282,000	December 31, 2022 December 31, 2021 Unsecured (a) Convertible notes due to AL-Bank $ 383,000 $ 503,000 (b) Convertible note with Diagonal Lending 100,000 - Unsecured (c) Convertible notes with fixed conversion features, in default 895,000 895,000 Convertible notes payable 1,378,000 1,398,000 Less debt discount (96,000 ) - Total Convertible notes payable $ 1,282,000 $ 1,398,000

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Notes Payable
Schedule of notes payable	March 31, 2023 December 31, 2022 Unsecured (a) Notes payable - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 286,000 286,000 (c) Note payable - EID loan 148,000 149,000 Secured (d) Notes payable – October 2022 1,000,000 1,000,000 (e) Notes payable - in default 6,000 6,000 (f) Notes payable – July 2022 165,000 211,000 Total notes payable principal outstanding 3,244,000 3,291,000 Less debt discount (136,000 ) (323,000 ) Total notes payable 3,108,000 2,968,000 Less current portion of notes payable, net of discount (2,966,000 ) (2,826,000 ) Long term notes payable $ 142,000 $ 142,000	December 31, 2022 December 31, 2021 Unsecured (a) Notes payable- $1,639,000 - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 286,000 310,000 (c) Note payable-EID loan 149,000 150,000 Secured (d) Notes payable – October 2022 1,000,000 - (e) Notes payable - in default 6,000 23,000 (f) Notes payable – July 2022 211,000 - Total notes payable principal outstanding 3,291,000 2,122,000 Less debt discount (323,000 ) - Total notes payable 2,968,000 2,122,000 Less current portion of notes payable, net of discount (2,826,000 ) (1,972,000 ) Long term notes payable $ 142,000 $ 150,000

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Derivative Financial Instruments
Schedule of derivative liability	At March 31, 2023 Issued 2023 At December 31, 2022 Stock Price $ 0.0026 $ 0.0054 $ 0.0055 Exercise Price $ 0.0034 $ 0.0034 $ 0.0034 Expected Life (Years) 0.79 1.00 0.80 Volatility 163 % 162 % 165 % Dividend Yield 0 % 0 % 0 % Risk-Free Interest Rate 4.64 % 4.84 % 4.73 % Fair value: Conversion feature $ 265,000 $ 175,000 $ 112,000	At December 31, 2022 Issued December 15, 2022 At December 31, 2021 Stock Price $ 0.0055 $ 0.0075 $ - Exercise Price $ 0.0034 $ 0.0034 $ - Expected Life (Years) 0.80 0.84 - Volatility 165 % 159 % - % Dividend Yield 0 % 0 % - % Risk-Free Interest Rate 4.73 % 4.65 % - % Fair value: Conversion feature $ 112,000 $ 164,000 $ -

Operating Lease (Tables)

Operating Lease (Tables)	12 Months Ended
	Dec. 31, 2022
Operating Lease
Schedule of lease expense and supplemental cash flow information	Year ended December 31, 2022 Year ended December 31, 2021 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 61,000 $ 56,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021 $ 58,000 $ 55,000 Weighted average remaining lease term – operating leases (in years) 1.1 2.1 Average discount rate – operating leases 10.0 % 10.0 %
Schedule of supplemental balance sheet information	At December 31, 2022 Operating leases Long-term right-of-use assets $ 54,000 Short-term operating lease liabilities $ 56,000 Long-term operating lease liabilities 1,000 Total operating lease liabilities $ 57,000
Schedule of maturities	Year Ending Operating Leases 2023 58,000 2024 - Total lease payments 58,000 Less: Imputed interest/present value discount (1,000 ) Present value of lease liabilities $ 57,000

Stockholders Deficit (Tables)

Stockholders Deficit (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Stockholders Deficit
Schedule of stock warrants activity	Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2023 362,729,077 $ 0.0045-0.75 $ 0.006 Granted 113,319,999 0.02 0.02 Canceled/Expired - - - Exercised - - - Balance outstanding and exercisable, March 31, 2023 476,049,076 $ 0.0045 – 0.75 $ 0.009	Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 27,405,475 $ 0.0045-2.90 $ 0.0117 Granted 55,000,000 0.05 0.05 Canceled/Expired - - - Exercised (13,424,241 ) - - Balance, January 1, 2021 68,981,234 0.0045-2.90 0.0421 Granted 394,353,319 0.0045 – 0.05 0.011 Canceled/Expired (605,476 ) 0.0085 – 2.90 0.035 Exercised (100,000,000 ) 0.08 – 2.90 0.165 Balance, December 31, 2022 362,729,077 $ 0.0045 – 0.75 $ 0.006 Balance outstanding and exercisable, December 31, 2022 362,729,077 $ 0.0045 – 0.75 $ 0.006
Schedule of warrants outstanding and exercisable	Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 346,666,653 4.47 $ 0.0045 0.02 124,339,999 4.90 0.02 0.05 5,000,000 3.48 0.50 0.75 42,424 1.68 0.75 $ 0.0045 - $0.75 476,049,076 4.46 $ 0.009	Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 333,333,319 4.79 $ 0.0045 0.005 13,333,334 2.87 $ 0.005 0.02 11,020,000 4.85 0.02 0.05 5,000,000 3.72 0.50 0.75 42,424 1.93 0.75 $ 0.0045 - $0.75 362,729,077 4.05 $ 0.006
Schedule grants of warrants on issuance of note Payable		Assumptions Exercise Price $ 0.01 Share Price $ 0.0079 Volatility % 268 % Risk Free Rate 4.41 % Expected Term (yrs.) 5 Dividend Rate 0 %
Schedule of grant of warrants for services		Assumptions Exercise Price $ 0.02 Share Price $ 0.02 Volatility % 233 % Risk Free Rate 2.88 % Expected Term (yrs.) 5 Dividend Rate 0 % Assumptions Exercise Price $ 0.01 Share Price $ 0.00752 Volatility % 224 % Risk Free Rate 4.34 % Expected Term (yrs.) 5 Dividend Rate 0 %

Stock Options (Tables)

Stock Options (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Stock Options
Schedule of stock options plan	Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2023 150,633,001 $ 0.0045- 1,121,250,000 $ 0.0307 Granted - - - Exercised (1 ) $ 1,121,250,000 1,121,250,000 Expired - - - Balance outstanding, March 31, 2023 150,633,000 $ 0.0045-3.00 $ 0.0306 Balance exercisable, March 31, 2023 120,591,791 $ 0.0045-3.00 $ 0.0371	Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 58,133,001 $ 0.005-1,121,250,000 $ 0.03704 Granted 67,500,000 0.005-0.0375 0.0104 Exercised (42,500,000 ) - - Expired - - - Balance, December 31, 2021 83,133,001 0.005-1,121,250,000 0.0274 Granted 67,500,000 0.0045 0.0045 Exercised - - - Expired - - - Balance outstanding, December 31, 2022 150,633,001 $ 0.0045-1,121,250,000 $ 0.0307 Balance exercisable, December 31, 2022 87,212,671 $ 0.0045-1,121,250,000 $ 0.0497
Schedule of stock option outstanding and exercisable	Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 3.0000 518,000 3.80 $ 3.0000 518,000 3.80 $ 3.000 2.0000 115,000 6.72 2.0000 115,000 6.72 2.0000 0.0375 65,000,000 8.73 0.0375 65,000,000 8.73 0.0375 0.005 17,500,000 7.84 0.0050 17,500,000 7.84 0.0050 0.0045 67,500,000 9.72 0.0045 37,458,791 9.97 0.0045 $ 0.0045 – 3.000 150,633,000 6.18 $ 0.0307 120,591,791 6.18 $ 0.0371	Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 0.01 $ 1,121,250,000 1 0.01 $ 1,121,250,000 3.0000 518,000 4.04 3.0000 518,000 4.04 3.0000 2.0000 115,000 6.97 2.0000 115,000 6.97 2.0000 0.0375 65,000,000 8.98 0.0375 65,000,000 8.98 0.0375 0.005 17,500,000 8.08 0.0050 17,500,000 8.08 0.0050 0.0045 67,500,000 9.97 0.0045 4,079,670 9.97 0.0045 $ 0.0045 – 1,121,250,000 150,633,001 6.43 $ 0.0307 87,212,671 6.43 $ 0.0497

Income Tax Provision (Tables)

Income Tax Provision (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Provision
Schedule of reconcilliation of fedral statutory income tax rate	December 31, 2022 December 31, 2021 Federal statutory income tax rate 21.0 % 21.0 % State tax, net of federal benefit 7.0 % 5.0 % Change in valuation allowance on net operating loss carry-forwards (28.0 ) (26.0 ) Effective income tax rate 0.0 % 0.0 %
Schedule of deferred tax assets and liabilities	December 31, 2022 December 31, 2021 Net deferred tax assets: Stock-based compensation $ 3,776,000 $ 702,000 Private placement costs 394,000 366,000 Operating lease liability 16,000 42,000 Loss on extinguishment of debt 1,858,000 1,697,000 Net operating loss carryforwards 7,362,000 5,946,000 Deferred tax assets 13,406,000 8,753,000 Less valuation allowance (13,406,000 ) (8,753,000 ) Total - -

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Commitment and Contingencies
Schedule of Onstream Media Corporation cases and their filing dates		Case Date Filed Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00191 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00192 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00193 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00194 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00195 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00196 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00197 (DWY) September 9, 2022
Schedule of Onstream Media Corporation	Case Date Filed Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00191 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00192 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00193 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00194 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00195 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00196 (DWY) September 9, 2022 Onstream Media Corporation v. Zerify Inc. Case No. 22-cv-00197 (DWY) September 9, 2022

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Total revenue	$ 22,000	$ 32,000	$ 103,000	$ 193,000
Software [Member]
Total revenue	19,000	32,000	96,000	193,000
Service [Member]
Total revenue	$ 3,000	$ 0	$ 7,000	$ 0

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies (Details 1) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Options to purchase common stock	150,633,000	83,133,001	150,633,001	83,133,001
Warrants to purchase common stock	476,049,076	68,981,234	362,729,077	68,981,234
Convertible notes	101,745,573	21	29,450,564	21
Convertible Series B Preferred stock	1,255,638	1,284,394	1,255,638	1,255,638
Total	729,683,287	153,398,650	544,068,280	153,369,894
Computer equipment [Member]
Estimated Useful Life (Years)			5 years
Computer software [Member]
Estimated Useful Life (Years)			3 years
Furniture and fixtures [Member]
Estimated Useful Life (Years)			7 years
Office equipment [Member]
Estimated Useful Life (Years)			7 years

Organization and Summary of S_6

Organization and Summary of Significant Accounting Policies (Details 2) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies
Options to purchase common stock	150,633,000	83,133,001	150,633,001	83,133,001
Warrants to purchase common stock	476,049,076	68,981,234	362,729,077	68,981,234
Convertible notes	101,745,573	21	29,450,564	21
Convertible Series B Preferred stock	1,255,638	1,284,394	1,255,638	1,255,638
Total	729,683,287	153,398,650	544,068,280	153,369,894

Organization and Summary of S_7

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 15, 2022	Dec. 31, 2020
Net loss	$ (1,669,000)	$ (2,867,000)	$ (8,829,000)	$ (17,245,000)
Net cash used in operating activities			4,258,000
Net loss	(1,669,000)	(2,867,000)	8,829,000	17,245,000
Total Stockholders' Deficit	(15,419,000)	(12,814,000)	(14,855,000)	(11,589,000)		$ (14,342,000)
Net cash used in operating activities	(873,000)	(1,060,000)	(4,258,000)	$ (3,063,000)
Notes payable aggregate amount	2,825,000		2,825,000
Cash on hand			192,000
Proceeds on the sale of common shares and warrants			$ 813,000
Sales deacreased percentage			47%	47%
Allowance for doubtful debts			$ 20,000	$ 20,000
Derivative liabilities	265,000		112,000	0	$ 164,000	$ 163,000
Advertising, sales and marketing costs			313,000	103,000
Research and development costs	157,000	$ 154,000	580,000	$ 566,000
Derivative liabilities	265,000		$ 112,000
FDIC insured limit	$ 250,000
Revenues [Member] | Four customer [Member]
Concentration Risk, Percentage		4%
Revenues [Member] | One customer [Member]
Concentration Risk, Percentage	40%	40%	39%	36%
Revenues [Member] | Two customer [Member]
Concentration Risk, Percentage	35%	35%	34%	32%
Revenues [Member] | Three customer [Member]
Concentration Risk, Percentage		17%		19%
Accounts Receivable [Member] | One customer [Member]
Concentration Risk, Percentage	10%		10%	65%
Accounts Receivable [Member] | Two customer [Member]
Concentration Risk, Percentage	10%			14%
BlockSafe Technologies, Inc. [Member]
Ownership interest held by company	49%
Ownership interest held by three executive officers	31%
Management fee per month	$ 36,000
Financing milestone, amount	1,000,000
Monthly management fee	$ 140,000
BST [Member]
Ownership interest held by company			49%
Ownership interest held by three executive officers			31%
Management fee per month			$ 36,000
Financing milestone, amount			1,000,000
Monthly management fee			$ 140,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property and equipment gross		$ 192,000	$ 153,000
Less accumulated depreciation		(156,000)	(153,000)
Property and equipment net	$ 34,000	36,000	0
Computer equipment [Member]
Property and equipment gross		84,000	82,000
Computer software [Member]
Property and equipment gross		45,000	44,000
Furniture and fixtures [Member]
Property and equipment gross		46,000	10,000
Office equipment [Member]
Property and equipment gross		$ 17,000	$ 17,000

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property and Equipment
Depreciation expense	$ 3,000	$ 4,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Secured
(a) Convertible notes due to AL-Bank	$ 373,000	$ 383,000	$ 503,000
Unsecured
(b) Convertible note with Diagonal Lending		100,000	0
(c) Convertible notes with fixed conversion features, in default	895,000	895,000	895,000
Total convertible notes principal outstanding	1,522,000	1,378,000	1,398,000
Debt discount	(204,000)	(96,000)	0
(b) Convertible note with Diagonal Lending	254,000	100,000
Convertible notes, net of discount	$ 1,318,000	$ 1,282,000	$ 1,398,000

Convertible Notes Payable (De_2

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Mar. 04, 2023	Feb. 06, 2023	Jan. 19, 2023
Unamortized debt discount	$ 323,000	$ 323,000
Interest expense	187,000
Debt discount	(136,000)	(323,000)	$ 0
Proceeds from convertible notes payable		100,000	0
Derivative liability	265,000	112,000
Financing costs		64,000	0
Convertible Notes Payable [Member]
Unamortized debt discount	204,000	96,000
Interest expense	46,000
Debt discount	100,000	100,000
Issued additional convertible notes payable				$ 54,000	$ 55,000	$ 45,000
Convertible notes payable, outstanding balance	254,000	$ 100,000
Proceeds from convertible notes payable	$ 154,000
Common stock shares issued upon conversion of debt	101,745,558	29,450,549
Derivative liability	$ 175,000	$ 164,000
Financing costs	$ 21,000	$ 64,000
Repayment penalty percentage	120%	120%
Conversion price percentage	65%	65%
Interest rate decriptions	The note is unsecured, bears interest at a rate of 12%, or 22% on default	The note is unsecured, bears interest at a rate of 12%, or 22% on default
Conversion feature of debentures, debt discount	$ 154,000
2005 Through 2007 [Member]
Maturity date description	due on various dates from March 2008 to March 2015, and are currently in default	due on various dates from March 2008 to March 2015, and are currently in default
Convertible notes payable, outstanding balance	$ 895,000	$ 895,000	895,000
Proceeds from convertible notes payable	$ 895,000	$ 895,000
Interest rate decriptions	notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum	The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum
2005 [Member]
Convertible notes payable, outstanding balance	$ 373,000	$ 383,000	503,000
(a) DART/Citco Global, in default	$ 543,000	$ 543,000
Interest rate	7.50%	7.50%
Total			$ 400,000
Monyhly payment	$ 10,000	$ 10,000
Remaining balance	143,000	143,000
Principal payments	$ 10,000	$ 120,000

Convertible Notes Payable - Rel

Convertible Notes Payable - Related Parties (Details Narrative) - Chief Executive Officer [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Due date	Dec. 31, 2023	Dec. 31, 2023
Interest rate	8%	8%
Convertible notes payable, outstanding balance	$ 268,000	$ 268,000	$ 268,000

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Unsecured notes payable-in default
(a) Notes payable- $1,639,000 - in default	$ 1,639,000	$ 1,639,000	$ 1,639,000
(b) Notes payable issued by BST - in default	286,000	286,000	310,000
Secured notes payable
(c) Note payable-EID loan	148,000	149,000	150,000
(d) Notes payable - October 2022	1,000,000	1,000,000	0
(e) Notes payable - in default	6,000	6,000	23,000
(f) Notes payable - July 2022	165,000	211,000	0
Total notes payable principal outstanding	3,244,000	3,291,000	2,122,000
Debt discount	(136,000)	(323,000)	0
Notes payable	3,108,000	2,968,000	2,122,000
Less current portion of notes payable	(2,966,000)	(2,826,000)	(1,972,000)
Long term notes payable	$ 142,000	$ 142,000	$ 150,000

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended	12 Months Ended
	May 15, 2020	Oct. 26, 2022	Jul. 31, 2022	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2019	Dec. 31, 2021	Dec. 31, 2020
Warrants granted		$ 260,000
Original issue discounts		200,000
Total debentures		460,000
Unamortized debt discount				$ 323,000	$ 323,000
Notes payable, outstanding balance					$ 286,000
Common stock, par value				$ 0.0001	$ 0.0001		$ 0.0001
Notes payable				$ 3,108,000	$ 2,968,000		$ 2,122,000
Interest expense				187,000
Leaving unamortized debt discount				136,000
Walleye Opportunities Master Fund Ltd [Member]
Original issue discounts		200,000
Notes payable, outstanding balance				1,000,000	1,000,000
Principal payments of promissory notes		1,000,000
Amount recieved		$ 800,000
Description about issuance of note payable		Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum
Common stock purchase of warrant		50,000,000
Warrant exercisble price		$ 0.01
Walleye Opportunities Master Fund Ltd [Member] | Maximum [Member]
Volume weighted average price of common stock		120%
Walleye Opportunities Master Fund Ltd [Member] | Minimum [Member]
Volume weighted average price of common stock		90%
EID Loan [Member]
Principal payment				1,000	1,000
Notes payable, outstanding balance				$ 148,000	149,000		$ 150,000
Loan borrowed amount	$ 150,000
Interest rate on loan	3.75%
Monthly payment on loan, description	Monthly principal and interest payments of $250 per month
Promissory Note [Member] | Securities Purchase Agreement [Member] | Walleye Opportunities Master Fund Ltd [Member]
Purchased promissory note aggregate principal amount		$ 1,000,000
Common stock, par value		$ 0.0001
One Note [Member]
Notes payable, outstanding balance					$ 310,000			$ 310,000
Principal payment						$ 319,000
Interest rate decriptions				The notes are unsecured, bearing interest at a rate of 8% per annum	The notes are unsecured, bearing interest at a rate of 8% per annum
Outstanding secured notes payable					$ 6,000
Note issued						$ 468,000
Interest rate of notes						8%	37%	37%
Amount payables					24,000
Note Payable Two [Member]
Principal payment				$ 46,000	64,000
Interest rate of notes			51%
Notes payable issue			$ 275,000
Notes payable issue maturity date			January 2024
Notes payable				165,000	211,000
Notes Payable [Member]
Notes payable, outstanding balance				$ 1,639,000	$ 1,639,000		$ 1,639,000
Interest rate decriptions				The notes are unsecured, bear interest at a rate of 8% through 14% per annum	The notes are unsecured, bear interest at a rate of 8% through 14% per annum
Unsecured [Member] | One Note [Member]
Notes payable, outstanding balance					$ 23,000
Outstanding secured notes payable				$ 6,000	6,000
Amount payables				$ 17,000	$ 17,000
Extinguished as debt settlement obligation transaction						$ 21,000

Notes Payable Related Parties (

Notes Payable Related Parties (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Notes payable - related parties	$ 693,000	$ 693,000	$ 693,000
Chief Executive Officer [Member]
Due date	Dec. 31, 2023	Dec. 31, 2023
Interest rate	8%	8%
Chief Executive Officer [Member] | Minimum [Member]
Interest rate	0%	0%
Chief Executive Officer [Member] | Maximum [Member]
Interest rate	10%	10%

VIE Financing Obligation (Detai

VIE Financing Obligation (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021
Financing obligation	$ 1,263,000	$ 1,263,000			$ 1,263,000
Unsecured Convertible Notes Payable [Member]
Tokens issued to unrelated parties				$ 50,000
Promissory note issued to unrelated parties				$ 776,000
BST [Member]
Financing obligation	$ 1,263,000	$ 1,263,000
Financing obligation description	as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100%	as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100%
Related Parties [Member] | Promissory note - various parties [Member]
Financing obligation			$ 315,000
Tokens issued to unrelated parties			$ 122,000

Contingent Payment Obligation (

Contingent Payment Obligation (Details Narrative) - USD ($)		3 Months Ended	12 Months Ended
	Sep. 06, 2017	Mar. 31, 2023	Dec. 31, 2022
Contingent payment obligation		$ 1,500,000	$ 1,500,000
Litigation funding agreement [Member] | Therium Inc. and VGL Capital, LLC [Member]
Contingent payment obligation	$ 1,500,000
Gross proceeds	$ 1,500,000
Contingent obligation, description	the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter

Derivative Financial Instrume_3

Derivative Financial Instruments (Details) - USD ($)		3 Months Ended	12 Months Ended
	Dec. 15, 2022	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Stock Price	$ 0.0075	$ 0.0026	$ 0.0055	$ 0
Exercise Price	$ 0.0034	$ 0.0034	$ 0.0034	$ 0
Expected life (in years)	10 months 2 days	9 months 14 days	9 months 18 days
Volatility	159%	163%	165%
Dividend Yield	0%	0%	0%
Risk-free interest rate	4.65%	4.64%	4.73%
Fair Value:
Conversion feature	$ 164,000	$ 265,000	$ 112,000	$ 0
Issued 2023 [Member]
Stock Price		$ 0.0054
Exercise Price		$ 0.0034
Expected life (in years)		1 year
Volatility		162%
Dividend Yield		0%
Risk-free interest rate		4.84%
Fair Value:
Conversion feature		$ 175,000

Derivative Financial Instrume_4

Derivative Financial Instruments (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 15, 2022
Derivative Financial Instruments
Net change in the fair value of derivative liabilities		$ 52,000	$ 219,000
Derivative liability	$ 265,000	112,000	0	$ 163,000	$ 164,000
Extinguishment of derivative liabilities	265,000	$ 112,000	$ 382,000	$ 382,000
Change in fair value of component of other income and expenses	22,000
Recognized derivative liabilities upon issuance of additional secured convertible debentures	$ 175,000

Operating Lease (Details)

Operating Lease (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lease Cost
Operating lease cost (included in general and administration in the Company's statement of operations)	$ 61,000	$ 56,000
Other Information
Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021	$ 58,000	$ 55,000
Weighted average remaining lease term - operating leases (in years)	1 year 1 month 6 days	2 years 1 month 6 days
Average discount rate - operating leases	10%	10%

Operating Lease (Details 1)

Operating Lease (Details 1) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating leases
Long-term right-of-use assets	$ 41,000	$ 54,000	$ 107,000
Short-term operating lease liabilities	44,000	56,000	39,000
Long-term operating lease liabilities	$ 0	1,000	$ 73,000
Total operating lease liabilities		$ 57,000

Operating Lease (Details 2)

Operating Lease (Details 2)	Dec. 31, 2022 USD ($)
Operating Lease
2023	$ 58,000
2024	0
Total lease payment	58,000
Less: Imputed interest/present value discount	(1,000)
Present value of lease liabilities	$ 57,000

Operating Lease (Details Narrat

Operating Lease (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2019	Dec. 31, 2022	Dec. 31, 2021
Operating Lease
Operating lease payments, monthly	$ 5,000
Operating lease, description	payments increasing 3% each year, and ending on January 31, 2024
Lease expenses		$ 61,000	$ 56,000

Stockholders Deficit (Details)

Stockholders Deficit (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Number of Warrant Shares
Number of warrants Beginning balance	362,729,077	68,981,234	27,405,475
Number of warrants Granted	113,319,999	394,353,319	55,000,000
Number of warrant shares, Canceled/Expired	0	(605,476)
Number of warrants Exercised		(100,000,000)	(13,424,241)
Number of warrants Outstsnding Ending	476,049,706	362,729,077	68,981,234
Number of warrants exercisable Ending	476,049,076	362,729,077
Exercise price range per share, Granted	$ 0.02	$ 0.0045	$ 0.05
Weighted Average Exercise Price
Weighted Average Exercise Price Beginning Balance	0.006	0.0421	0.0117
Weighted Average Exercise Price, Granted	0.02	0.011	0.05
Weighted Average Exercise Price, Canceled/Expired	0	0.035
Weighted Average Exercise Price, Exercised	0	0.165
Weighted Average Exercise Price Outstanding Ending Balacce	0.0045	0.006	0.0421
Weighted Average Exercise Price Exercisable Ending Balacce	0.009	0.006
Exercise Price Range Per Share Exercisable Ending balance		0.0045	1,121,250,000
Minimum [Member]
Number of Warrant Shares
Exercise price range per share, Granted			0.005
Weighted Average Exercise Price
Weighted Average Exercise Price, Granted		0.0045
Exercise Price Range Per Share, Beginning balance	0.0045	0.0045	0.0045
Exercise Price Range Per Share, Exercised		0.08
Exercise Price Range Per Share, Canceled/Expired		0.0085
Exercise Price Range Per Share Outstanding Ending	0.0045	0.0045	0.0045
Exercise Price Range Per Share Exercisable Ending balance	0.0045	0.0045
Maximum [Member]
Number of Warrant Shares
Exercise price range per share, Granted			0.0375
Weighted Average Exercise Price
Weighted Average Exercise Price, Granted		0.05
Exercise Price Range Per Share, Beginning balance	0.75	2.90	2.90
Exercise Price Range Per Share, Exercised		2.90
Exercise Price Range Per Share, Canceled/Expired		2.90
Exercise Price Range Per Share Outstanding Ending	0.75	0.75	$ 2.90
Exercise Price Range Per Share Exercisable Ending balance	$ 0.75	1,121,250,000
Exercise Price Range Per Share Exercisable Ending balance		$ 0.75

Stockholders Deficit (Details 1

Stockholders Deficit (Details 1) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Warrant [Member]
Average Remaining Contractual Life (in years)	4 years 5 months 19 days	4 years 9 months 14 days
Weighted Average Exercise Price	$ 0.0045	$ 0.0045
Number Outstanding	346,666,653	333,333,319
Range of Exercise Prices	$ 0.0045	$ 0.0045
Warrant One [Member]
Average Remaining Contractual Life (in years)	3 years 5 months 23 days	2 years 10 months 13 days
Weighted Average Exercise Price	$ 0.50	$ 0.005
Number Outstanding	5,000,000	13,333,334
Range of Exercise Prices	$ 0.05	$ 0.005
Warrant Two [Member]
Average Remaining Contractual Life (in years)	4 years 10 months 24 days	4 years 10 months 6 days
Weighted Average Exercise Price	$ 0.02	$ 0.02
Number Outstanding	124,339,999	11,020,000
Range of Exercise Prices	$ 0.02	$ 0.02
Warrant Three [Member]
Average Remaining Contractual Life (in years)		3 years 8 months 19 days
Weighted Average Exercise Price		$ 0.50
Number Outstanding		5,000,000
Range of Exercise Prices		$ 0.05
Warrant Four [Member]
Average Remaining Contractual Life (in years)	1 year 8 months 4 days	1 year 11 months 4 days
Weighted Average Exercise Price	$ 0.75	$ 0.75
Number Outstanding	42,424	42,424
Range of Exercise Prices	$ 0.75	$ 0.75
Warrant Total [Member]
Average Remaining Contractual Life (in years)	4 years 5 months 15 days	4 years 18 days
Weighted Average Exercise Price	$ 0.009	$ 0.006
Number Outstanding	476,049,076	362,729,077
Warrant Total [Member] | Maximum [Member]
Range of Exercise Prices	$ 0.75	$ 0.75
Warrant Total [Member] | Minimum [Member]
Range of Exercise Prices	$ 0.0045	$ 0.0045

Stockholders Deficit (Details 2

Stockholders Deficit (Details 2) - Warrant Services [Member] - $ / shares	1 Months Ended
	Oct. 21, 2022	Jul. 31, 2022
Exercise Prices	$ 0.01	$ 0.02
Share price	$ 0.00752	$ 0.02
Volatility	224%	233%
Risk Free Rate	4.34%	2.88%
Expected term (yrs.)	5 years	5 years
Dividend Rate	0%	0%

Stockholders Deficit (Details 3

Stockholders Deficit (Details 3) - Warrant Note Payable [Member]	1 Months Ended
	Oct. 26, 2022 $ / shares
Exercise Prices	$ 0.01
Share price	$ 0.0079
Volatility	268%
Risk Free Rate	4.41%
Expected term (yrs.)	5 years
Dividend Rate	0%

Stockholders Deficit (Details N

Stockholders Deficit (Details Narrative) - USD ($)			1 Months Ended						3 Months Ended		12 Months Ended
	May 05, 2022	Jan. 10, 2011	Apr. 30, 2023	Oct. 26, 2022	Oct. 21, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2019
Common Shares issued for cash						50,000,000					50,000,000
Shares issued for cash value											$ 1,440,000
Deemed dividend											$ 1,787,000	$ 0
Cash recieved						$ 500,000
Issued shares of stock warrants granted											100,000,000
Preferred stock, shares authorized									10,000,000		10,000,000	10,000,000
Preferred stock, per share									$ 0.10		$ 0.10	$ 0.10
Warrants exercisable price	$ 0.02					$ 0.01					$ 0.05
Preferred stock, shares outstanding									0		0	0
Purchase shares of common stock for financing services											150,000,000
Common stock issued upon warrant exercised												12,349,726
Common stock issued												45,150,500
Common stock issued												45,150,500
Common stock issued for service, share												6,569,000
Common stock issued for service, value										$ 6,000	$ 423,000	$ 181,000
Preferred stock value									$ 0		$ 0	$ 0
Qualified Regulation A Offering [Member] | Certain Investors [Member]
Issued warrants to purchase shares of common stock			14,000,000								35,319,999
Warrants fully vested, exercisable			$ 0.0045								$ 0.02
Private Placement Under Rule Regulation D [Member] | Certain Investors [Member]
Warrants fully vested, exercisable			$ 0.0036								$ 0.02
October, 21 2010 [Member]
Preferred stock, shares authorized											10,000,000
Preferred stock, per share											$ 0.10
Additional shares of preferred stock											10,000,000
Warrant Total [Member]
Issued shares of stock warrants granted	50,000,000
Shares issued for cash value, direct fees and commission	$ 940,000
Warrants exercisable price	$ 0.02										$ 0.05
Warrants issued to purchase common shares											50,000,000
Number of Warrants exercised												90,908	90,908
Warrant exercised, share												13,333,333
Common stock issued upon warrant exercised												12,349,726
Fair value of common stock issued												$ 6,569,000
Intrinsic value of warrants											$ 13,000	$ 473,000
Warrant Note Payable [Member]
Vested, exercisable price				$ 0.01
Estimated fair value				$ 260,000
Grant of Warrants For Servicesl [Member]
Vested, exercisable price					$ 0.01		$ 0.02
Purchase shares of common stock for financing services					50,000,000		3,000,000
Estimated fair value					$ 372,000		$ 63,000
Warrants exercisable expire term					5 years		5 years
Warrant Holder [Member]
Deemed dividend											$ 1,787,000
Warrants exercisable price											$ 0.0045
Vested, exercisable price											$ 0.01
Purchase shares of common stock for financing services											150,000,000
Additional warrants											183,333,320
Series B Preferred Stock [Member]
Preferred stock, shares authorized									100,000,000		100,000,000	100,000,000
Preferred stock, per share									$ 0.10		$ 0.10	$ 0.10
Preferred stock, shares outstanding									36,667		36,667	36,667
Preferred stock, shares designated		100,000,000
Aggregate amount		$ 987,000
Preferred stock value		$ 329,000							$ 4,000		$ 4,000	$ 4,000
Preferred stock, descriptions		such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share									such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share
Initial price of preferred stock		$ 2.50									$ 2.50
Common Class Shares [Member] | November 2020 [Member]
Common Shares issued for cash											40,100,000	119,666,450
Shares issued for cash value											$ 180,000	$ 5,368,000
Warrants issued to purchase common stock											8,020,000	55,000,000
Warrants issued to purchase common stock exercisable price												$ 0.005
Warrants issued to purchase common stock expiration period											five years	five years
Common stock issued for service, share											30,105,936	3,365,138
Common stock issued for service, value											$ 423,000	$ 181,000
Stock issued for business purchase, shares						10,000,000		2,500,000				500,000
Stock issued for business purchase, value						$ 127,000		$ 56,000				$ 36,000
Common stock issued upon conversion of convertible notes payable and accrued interest, share	16,168,589											16,168,589
Shares of warrants	605,476
Common stock issued upon conversion of convertible notes payable and accrued interest, value												$ 1,035,000
Common stock issued for debt settlement, share												460,829
Common stock issued for debt settlement, value	$ 165,000											$ 88,000
Common Stocks [Member] | Qualified Regulation A Offering [Member]
Issued shares of common stock in exchange for cash			$ 261,000						$ 795,000		$ 795,000
Issued shares of common stock			70,000,000						176,599,998		176,599,998
Common Stocks [Member] | Private Placement Under Rule Regulation D [Member]
Issued shares of common stock in exchange for cash									$ 18,000		$ 18,000
Issued shares of common stock			10,000,000						78,000,000		78,000,000

Stock Options (Details)

Stock Options (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Stock options
Number of Options Shares, Beginning balance	150,633,000	83,133,001	58,133,001
Number of Options Shares, Granted		67,500,000	67,500,000
Number of Options Shares, Exercised	(1)		(42,500,000)
Number of Options Shares, Ending balance	150,633,001	150,633,001	83,133,001
Number of Options Shares exercisable Ending	120,591,791	87,212,671
Weighted Average Exercise Price
Weighted Average Exercises Price Beginning Balance	$ 0.0307	$ 0.0274	$ 0.03704
Number of Options Shares, Exercised	1		42,500,000
Weighted Average Exercise Price, Granted	$ 1,121,250,000	0.0045	$ 0.0104
Weighted Average Exercise Price Outstanding Ending Balacce	0.0306	0.0307	0.0274
Weighted Average Exercise Price Exercisable Ending Balacce	0.0371	0.0497
Exercise Price Range Per Share, Beginning balance		0.005	0.005
Exercise Price Range Per Share ,Granted	0.02	0.0045	0.05
Exercise Price Range Per Share Exercisable Ending balance		0.0045	1,121,250,000
Exercise Price Range Per Share. Exercised	1,121,250,000
Exercise Price Range Per Share, Ending balance		0.0045	0.005
Minimum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share ,Granted			0.005
Exercise Price Range Per Share Exercisable Ending balance	0.0045	0.0045
Minimum [Member] | Stock Option [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	0.0045
Exercise Price Range Per Share Exercisable Ending balance	0.0045
Exercise Price Range Per Share, Ending balance	0.0045
Maximum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance		1,121,250,000	1,121,250,000
Exercise Price Range Per Share ,Granted			$ 0.0375
Exercise Price Range Per Share Exercisable Ending balance	0.75	$ 1,121,250,000
Maximum [Member] | Stock Option [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	1,121,250,000
Exercise Price Range Per Share Exercisable Ending balance	3
Exercise Price Range Per Share, Ending balance	$ 3

Stock Options (Details 1)

Stock Options (Details 1) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Option Exercisable [Member]
Weighted average exercise price	$ 0.0371	$ 0.0497
Weighted average remaining contractual life (years)	6 years 2 months 4 days	6 years 5 months 4 days
Number of warrants exercisable	120,591,791	87,212,671
Option Exercisable [Member] | Exercise Prices Two [Member]
Weighted average exercise price	$ 2	$ 3
Weighted average remaining contractual life (years)	6 years 8 months 19 days	4 years 14 days
Number of warrants exercisable	115,000	518,000
Option Exercisable [Member] | Exercise Prices Three [Member]
Weighted average exercise price	$ 0.0375	$ 2
Weighted average remaining contractual life (years)	8 years 8 months 23 days	6 years 11 months 19 days
Number of warrants exercisable	65,000,000	115,000
Option Exercisable [Member] | Exercise Prices Four [Member]
Weighted average exercise price	$ 0.0050	$ 0.0375
Weighted average remaining contractual life (years)	7 years 10 months 2 days	8 years 11 months 23 days
Number of warrants exercisable	17,500,000	65,000,000
Option Exercisable [Member] | Exercise Prices One [Member]
Weighted average remaining contractual life (years)	3 years 9 months 18 days	3 days
Number of warrants exercisable	518,000	1
Weighted average exercise price	$ 3	$ 1,121,250,000
Option Exercisable [Member] | Exercise Prices Six [Member]
Weighted average exercise price		$ 0.0045
Weighted average remaining contractual life (years)		9 years 11 months 19 days
Number of warrants exercisable		67,500,000
Options Outstanding [Member]
Weighted average exercise price	$ 0.0307
Weighted average remaining contractual life (years)	6 years 2 months 4 days	6 years 5 months 4 days
Number of warrants outstanding	150,633,000	150,633,001
Options Outstanding [Member] | Minimum [Member]
Range of exercise prices	$ 0.0045
Options Outstanding [Member] | Maximum [Member]
Range of exercise prices	$ 3
Options Outstanding [Member] | Exercise Prices Two [Member]
Weighted average remaining contractual life (years)	6 years 8 months 19 days	4 years 14 days
Number of warrants outstanding	115,000	518,000
Range of exercise prices	$ 2
Weighted average exercise price	$ 2	$ 3
Options Outstanding [Member] | Exercise Prices Three [Member]
Weighted average remaining contractual life (years)	8 years 8 months 23 days	6 years 11 months 19 days
Number of warrants outstanding	65,000,000	115,000
Range of exercise prices	$ 0.0375
Weighted average exercise price	0.0375	$ 2
Options Outstanding [Member] | Exercise Prices Four [Member]
Weighted average exercise price	$ 0.0050	$ 0.0375
Weighted average remaining contractual life (years)	7 years 10 months 2 days	8 years 11 months 23 days
Number of warrants outstanding	17,500,000	65,000,000
Range of exercise prices	$ 0.005
Options Outstanding [Member] | Exercise Prices Five [Member]
Weighted average exercise price	$ 0.0045	$ 0.0050
Weighted average remaining contractual life (years)	9 years 8 months 19 days	8 years 29 days
Range of exercise prices	$ 0.0045
Number of warrants exercisable	67,500,000	17,500,000
Options Outstanding [Member] | Exercise Prices One [Member]
Weighted average remaining contractual life (years)	3 years 9 months 18 days	3 days
Number of warrants outstanding	518,000	1
Range of exercise prices	$ 3
Weighted average exercise price	$ 3	$ 1,121,250,000
Option Exercisable [Member] | Exercise Prices Five [Member]
Weighted average remaining contractual life (years)	9 years 11 months 19 days	8 years 29 days
Number of warrants outstanding	37,458,791	17,500,000
Weighted average exercise price	$ 0.0045	$ 0.0050
Option Exercisable [Member] | Exercise Prices Six [Member]
Weighted average remaining contractual life (years)		9 years 11 months 19 days
Number of warrants outstanding		4,079,670
Weighted average exercise price		$ 0.0045

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Nov. 30, 2017
Intrinsic value of outstanding options	$ 0		$ 76,000
Share based compensation			2,958,000	$ 32,000
Unamortized stock compensation			$ 562,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			400,000,000		100,000,000
Total fair value	$ 292,000	$ 1,636,000	$ 3,425,000	$ 6,757,000
Options, Grants in Period			67,500,000	67,500,000
Stock Option [Member]
Option shares			2,500,000
Intrinsic value of outstanding options			$ 76,000	$ 3,225,000
Exercise price			$ 0.0045	$ 0.005
Total fair value			$ 594,000
Stock compensation expense, Additional				$ 2,712,000
Common stock, shares issued upon cashless exercise of options				39,955,655
Options, Grants in Period				67,500,000
Discount rate			3.79%	1.46%
Volatility rate			394%	137%
Options, exercised during period				42,500,000
Options outstanding, estimated life			10 years	10 years
Stock Option [Member] | February 2021 [Member]
Share based compensation			$ 3,675,000	$ 368,000
Options outstanding, estimated life			10 years
Stock option granted			12,250,000

Income Tax Provision (Details)

Income Tax Provision (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Provision
Federal statutory income tax rate	21%	21%
State tax, net of federal benefit	7%	5%
Change in valuation allowance on net operating loss carry-forwards	(28.00%)	(26.00%)
Effective income tax rate	0%	0%

Income Tax Provision (Details 1

Income Tax Provision (Details 1) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Operating lease liability	$ 57,000
Income Tax Provision [Member]
Stock-based compensation	3,776,000	$ 702,000
Private placement costs	394,000	366,000
Operating lease liability	16,000	42,000
Loss on extinguishment of debt	1,858,000	1,697,000
Net operating loss carryforwards	7,362,000	5,946,000
Gross deferred tax assets	13,406,000	8,753,000
Net deferred tax assets	0	0
Less valuation allowance	$ (13,406,000)	$ (8,753,000)

Income Tax Provision (Details N

Income Tax Provision (Details Narrative) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Federal [Member]
Net operating loss carry-forwards	$ 30.2	$ 26.5
Carryforwards expiry year	2041
State [Member]
Net operating loss carry-forwards	$ 14.7	$ 13.2
Carryforwards expiry year	2041

Commitment and Contingencies (D

Commitment and Contingencies (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Onstream Media Corporation V Zerify Inc [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc One [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Two [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Three [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Four [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Five [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Six [Member]
Date of filing	Sep. 09, 2022	Sep. 09, 2022

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)			1 Months Ended			3 Months Ended	12 Months Ended
	Sep. 05, 2023	Jul. 05, 2023	Jun. 30, 2023	May 31, 2023	Apr. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jul. 17, 2023	May 23, 2023	Dec. 31, 2021
Common stock, shares authorized						10,000,000,000	10,000,000,000			4,000,000,000
Subsequent Event [Member]
Common stock, shares authorized									10,000,000,000
Convertible note payable								$ 44,000
Aggregate principal amount		$ 50,000
Interest rate		12%
Additional common share		219,780,219
Chief Excutive Officer [Member] | Subsequent Event [Member]
Discription of agreement				the Company executed a Revenue Based Financing Agreement personally guaranteed by its Chief Executive Officer in the amount of $75,000 in an arm’s length lender. The agreement becomes due and is payable daily pursuant to an Agreement for Deposits and Direct Collections. The agreement bears a specified percentage rate of 15% and has an origination fee of $1,740
Chief Executive Officer and Additionally Secured By Execution Security Agreement And Guaranty [Member] | Subsequent Event [Member]
Discription of agreements				the Company executed a Revenue Purchase Agreement personally guaranteed by its Chief Executive Officer and additionally secured by the execution of the Security Agreement and Guaranty. The amount is for $40,000 and becomes due and is payable daily pursuant to a Direct Deposit Agreement for daily deposit of $600. The agreement bears a specified purchased percentage rate of 15% and has an underwriting fee together with a program fee
Chief Executive Officer and secured by a perfected [Member] | Subsequent Event [Member]
Discription of agreement1			the Company executed Future Receivables Sale and Purchase Agreement in the amount of $70,000.00 personally guaranteed by its Chief Executive Officer and secured by a perfected, priority lien on the assets of the Company. This agreement indicates an initial daily installment of $6,995.53 and has an underwriting fee of $14,000.00 together with a $250.00 monthly service fee
Letter Agreement With Walleye Inc Member | Subsequent Event [Member]
Warrants exercise price	$ 0.0036
Warrants issue	138,888,889
Qualified Regulation A Offering [Member] | Certain Investors [Member]
Issued warrants to purchase shares of common stock					14,000,000		35,319,999
Range of exercise prices					$ 0.0045		$ 0.02
Warrant per unit price					0.0225
Private Placement Under Rule Regulation D [Member] | Certain Investors [Member]
Range of exercise prices					0.0036		$ 0.02
Warrant per unit price					$ 0.018
Common Stocks [Member] | Qualified Regulation A Offering [Member]
Issued shares of common stock in exchange for cash					$ 261,000	$ 795,000	$ 795,000
Issued shares of common stock					70,000,000	176,599,998	176,599,998
Common Stocks [Member] | Private Placement Under Rule Regulation D [Member]
Issued shares of common stock in exchange for cash						$ 18,000	$ 18,000
Issued shares of common stock					10,000,000	78,000,000	78,000,000